← 產業報告目錄

Biomaterials Market by Type [Metallic (Gold, Magnesium), Ceramic (Aluminum Oxide, Carbon), Polymer (Polyethylene, Polyester), Natural (Hyaluronic acid, Collagen, Gelatin)], Application (Orthopedic, Dental, CVD, Ophthalmology) - Global Forecast to 2030

出版商 MarketsandMarkets產業別 Healthcare & Life Sciences出版日期 2026-01-26頁數 619報告編號 BT1556

授權報價

Single User Licence$4,950 USD
Multi User Licence$6,650 USD
Corporate User Licence$8,150 USD
Global User Licence$10,000 USD
洽詢購買 申請 Sample

報告摘要

The global Biomaterials market is projected to reach USD 68.93 billion by 2030 from USD 48.36 billion in 2025, at CAGR of 7.3% from 2025 to 2030. The expansion of the Global Biomaterials market has been fueled by the advancements in healthcare facilities and systems, and the rising advancements in smart, biocompatible, and 3D-printed biomaterials. In 2024, The metallic biomaterials held the highest share in the Global Biomaterials market by type. The market is segmented into Metallic Biomaterials, Polymeric Biomaterials, Ceramic Biomaterials, Natural Biomaterials. The highest share by type was of metallic biomaterials due to their wide application in orthopedic, dental, and cardiovascular fields. The mechanical properties make them the suitable for application in implants such as joint replacements, fracture fixation devices, dental implants, and stints. The commonly used biomaterials are titanium and its alloys, stainless steel, cobalt chromoly alloys, and more recently, biodegradable metal alloys like magnesium-based metal. These exhibit remarkable resistance to fatigue failure, corrosion, and remarkable compatibility. They were also found to be safe for long-term use in a physiological environment. However, constant progress in surface modification technologies such as surface modification through coating and surface treatment has greatly improved their osseointegration, friction, and resistance to infections. Moreover, rising surgical procedures, an ageing population, and an increase in musculoskeletal and cardiac disorders are expected to propel the demand for metallic biomaterials across the globe, consolidating their strong position in the global biomaterials. “Joint replacement segment reported for the highest share of the orthopedic application segment in 2024.” Within the application segment, the Global Biomaterials market is divided into Cardiovascular, Orthopedic, Ophthalmology, Dental, Plastic Surgery, Tissue engineering, neurological application Wound Healing, Urinary application, and Other Applications. In 2024, Joint replacement represents the leading segment in orthopedic applications in the global biomaterials. Due to an increasing number of people suffering from degenerative joint diseases like osteoarthritis and rheumatoid arthritis. factors like an aging population, and an increasing rate of obesity have also led to an increasing number of people undergoing knee, shoulder, or hip replacements. However, materials used in joint replacements, have improved strength, durability, or biocompatibility that makes these materials highly suitable for applications involving heavy loading. Advances in implant design, surface technology, or method of implantation also continue to increase patient survival with these implants. Furthermore, increasing utilization of minimal invasiveness in surgeries, increasing availability of orthopedic care in developing nations, or ever-improving implant technologies continue to drive this market. APAC accounted for the fastest growing market share in the global Biomaterials market from 2025 to 2030. The biomaterials market is segmented into North America, Europe, Asia Pacific, Latin America, Middle East and Africa. APAC region is projected to grow at the highest CAGR during the forecast period . This surge is driven by rapid healthcare infrastructure expansion in China, India, and Japan, alongside booming medical tourism and rising chronic disease burdens like orthopedics and cardiology. An aging population, government R&D investments, and adoption of 3D-printed implants and bioresorbable polymers fuel demand for advanced metallic, polymeric, and ceramic solutions in joint replacements, stents, and tissue engineering. Local manufacturing hubs and regulatory streamlining further accelerate market penetration, positioning APAC as a key innovation powerhouse. The primary interviews conducted for this report can be categorized as follows: • By Respondent: Supply Side-70% and Demand Side-30% • By Designation: Managers-45%, CXO and Directors-30%, and Executives-25% • By Region: North America-40%, Europe-25%, the Asia Pacific-25%, Latin America-5%, and the Middle East & Africa-5% List of Key Companies Profiled in the Report: Key players in the Global Biomaterials market include BASF SE (Germany), Covestro AG (Germany), Celanese Corporation (US), Carpenter Technology Corporation (US), DSM (Netherlands), Corbion NV (Netherlands), Evonik Industries AG (Germany), Victrex Plc (UK), CeramTec GmbH (Germany), Mitsubishi Chemical Group Corporation (Japan), CoorsTek Inc. (US), Berkeley Advanced Biomaterials (US), CAM Bioceramics B.V. (Netherlands), Zeus Company Inc. (US), AMETEK Inc. (US), and GELITA AG (Germany). Research Coverage: This research report categorizes the Global Biomaterials market, By Type: Metallic Biomaterials, Polymeric Biomaterials, Ceramic Biomaterials, Natural Biomaterials, By Application: Cardiovascular Orthopaedic, Dental, Plastic Surgery, Urinary, Wound Healing, Tissue Engineering, Ophthalmology, Neurological/Central Nervous System, Other Applications. and by region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the Biomaterials market. A detailed analysis of the key industry players has been done to provide insights into their business overview, products, solutions, key strategies, collaborations, partnerships, and agreements. New approvals/launches, collaborations, acquisitions, and recent developments associated with the Global Biomaterials market. Key Benefits of Buying the Report: The report will help market leaders and new entrants by providing them with the closest approximations of the revenue numbers for the overall Biomaterials market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their businesses and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges. The report provides insights on the following pointers: • Analysis of key drivers (Rising advancements in smart, biocompatible, and 3D-printed biomaterials, Advancements in healthcare facilities and systems), restraints (High development and production costs associated with advanced biomaterials.), opportunities (Expanding applications in tissue engineering and regenerative medicine.) and Challenges (Concerns related to biocompatibility, safety, and adverse immune responses). • Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities in the Global Biomaterials market • Market Development: Comprehensive information about lucrative markets - the report analyses the market across varied regions. • Market Diversification: Exhaustive information about untapped geographies, recent developments, and investments in the Global Biomaterials market • Competitive Assessment: In-depth assessment of market shares, growth strategies, and product offerings of leading players. A detailed analysis of the key industry players has been done to provide insights into their key strategies, product launches/ approvals, pipeline analysis, acquisitions, partnerships, agreements, collaborations, other recent developments, investment and funding activities, brand/product comparative analysis, and vendor valuation and financial metrics of the Global Biomaterials market.
目錄 Table of Contents
1 INTRODUCTION 57 1.1 STUDY OBJECTIVES 57 1.2 MARKET DEFINITION 57 1.2.1 INCLUSIONS & EXCLUSIONS 58 1.3 STUDY SCOPE 59 1.3.1 MARKET SEGMENTATION 59 1.3.2 REGIONAL SCOPE 60 1.3.3 YEARS CONSIDERED 60 1.3.4 CURRENCY CONSIDERED 60 1.4 RESEARCH LIMITATIONS 61 1.5 STAKEHOLDERS 61 1.6 SUMMARY OF CHANGES 61 2 EXECUTIVE SUMMARY 63 2.1 KEY INSIGHTS & MARKET HIGHLIGHTS 63 2.2 KEY MARKET PARTICIPANTS: SHARE INSIGHTS & STRATEGIC DEVELOPMENTS 64 2.3 DISRUPTIVE TRENDS SHAPING BIOMATERIALS MARKET 65 2.4 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS 66 2.5 SNAPSHOT: GLOBAL MARKET SIZE, GROWTH RATE, AND FORECAST 67 3 PREMIUM INSIGHTS 68 3.1 BIOMATERIALS MARKET OVERVIEW 68 3.2 NORTH AMERICA: BIOMATERIALS MARKET, BY TYPE AND COUNTRY, 2025 69 3.3 BIOMATERIALS MARKET: GEOGRAPHIC SNAPSHOT 70 4 MARKET OVERVIEW 71 4.1 INTRODUCTION 71 4.2 MARKET DYNAMICS 71 4.2.1 DRIVERS 72 4.2.1.1 Rising advancements in smart, biocompatible, and 3D printed biomaterials 72 4.2.1.2 Advancements in healthcare systems, physical infrastructure, and reimbursement frameworks 73 4.2.1.3 Growing demand for biomaterials in wound healing and plastic surgery 73 4.2.1.4 Increasing use of biomaterials in multiple therapeutic areas 74 4.2.2 RESTRAINTS 74 4.2.2.1 High development and production cost of advanced biomaterials 74   4.2.3 OPPORTUNITIES 75 4.2.3.1 Expanding applications in tissue engineering and regenerative medicine 75 4.2.3.2 Development of novel biomaterials 75 4.2.4 CHALLENGES 76 4.2.4.1 Concerns related to biocompatibility, safety, and adverse immune responses 76 4.3 UNMET NEEDS & WHITE SPACES 76 4.4 INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES 77 4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS 77 5 INDUSTRY TRENDS 79 5.1 PORTER’S FIVE FORCES ANALYSIS 79 5.1.1 THREAT OF NEW ENTRANTS 80 5.1.2 THREAT OF SUBSTITUTES 80 5.1.3 BARGAINING POWER OF BUYERS 80 5.1.4 BARGAINING POWER OF SUPPLIERS 80 5.1.5 INTENSITY OF COMPETITIVE RIVALRY 80 5.2 MACROECONOMIC OUTLOOK 81 5.2.1 GDP TRENDS AND FORECAST 81 5.2.2 TRENDS IN GLOBAL BIOMATERIALS MARKET 82 5.3 VALUE CHAIN ANALYSIS 82 5.4 ECOSYSTEM ANALYSIS 84 5.4.1 ROLE IN ECOSYSTEM 85 5.5 PRICING ANALYSIS 86 5.5.1 INDICATIVE SELLING PRICE OF BIOMATERIALS, BY KEY PLAYER, 2025 86 5.5.2 INDICATIVE SELLING PRICE OF BIOMATERIALS, BY REGION, 2025 87 5.6 TRADE ANALYSIS 88 5.6.1 IMPORT DATA FOR HS CODE 7221 (STAINLESS STEEL), 2021–2025 88 5.6.2 EXPORT DATA FOR HS CODE 7221 (STAINLESS STEEL), 2021–2025 89 5.6.3 IMPORT VOLUME FOR HS 7221 (STAINLESS STEEL), 2021–2025 90 5.6.4 EXPORT VOLUME FOR HS CODE 7221 (STAINLESS STEEL), 2021–2025 91 5.6.5 IMPORT DATA FOR HS CODE 284329 (SILVER), 2021–2025 92 5.6.6 EXPORT DATA FOR HS CODE 284329 (SILVER), 2021–2025 93 5.6.7 IMPORT VOLUME FOR HS 284329 (SILVER), 2021–2025 94 5.6.8 EXPORT VOLUME FOR HS CODE 284329 (SILVER), 2021–2025 95 5.6.9 IMPORT DATA FOR HS CODE 281820 (ALUMINUM OXIDE), 2021–2025 96 5.6.10 EXPORT DATA FOR HS CODE 281820 (ALUMINUM OXIDE), 2021–2025 97 5.6.11 IMPORT VOLUME FOR HS CODE 281820 (ALUMINUM OXIDE), 2021–2025 98 5.6.12 EXPORT VOLUME FOR HS CODE 281820 (ALUMINUM OXIDE), 2021–2025 99 5.6.13 IMPORT DATA FOR HS CODE 3910 (SILICONE), 2021–2025 100 5.6.14 EXPORT DATA FOR HS CODE 3910 (SILICONE), 2021–2025 101 5.6.15 IMPORT VOLUME FOR HS 3910 (SILICONE), 2021–2025 102 5.6.16 EXPORT VOLUME FOR HS CODE 3910 (SILICONE), 2021–2025 103 5.7 KEY CONFERENCES & EVENTS, 2026–2027 104 5.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS 104 5.9 INVESTMENT & FUNDING SCENARIO 105 5.10 CASE STUDY ANALYSIS 106 5.10.1 SCALING MEDICAL-GRADE POLYMER SUPPLY THROUGH INTEGRATED VERBUND MANUFACTURING 106 5.10.2 STRENGTHENING HIGH-PERFORMANCE POLYMER PLATFORMS FOR REGULATED BIOMATERIALS APPLICATIONS 107 5.10.3 ADVANCING BIORESORBABLE AND BIOCOMPATIBLE MATERIALS FOR CLINICAL AND COMMERCIAL SCALE-UP 107 5.11 IMPACT OF 2025 US TARIFF ON BIOMATERIALS MARKET 108 5.11.1 INTRODUCTION 108 5.11.2 KEY TARIFF RATES 108 5.11.3 PRICE IMPACT ANALYSIS 109 5.11.4 IMPACT ON COUNTRY/REGION 109 5.11.4.1 North America 109 5.11.4.2 Europe 110 5.11.4.3 Asia Pacific 110 5.11.5 IMPACT ON END-USE INDUSTRIES 111 5.11.5.1 Medical device manufacturers 111 5.11.5.2 Pharmaceutical & biotechnology companies 111 6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS 112 6.1 TECHNOLOGY ANALYSIS 112 6.1.1 KEY TECHNOLOGIES 112 6.1.1.1 Precision technologies 112 6.1.1.2 Biomimetics 112 6.1.2 ADJACENT TECHNOLOGIES 113 6.1.2.1 3D bioprinting 113 6.1.2.2 Electrospinning 113 6.2 TECHNOLOGY/PRODUCT ROADMAP 114 6.3 PATENT ANALYSIS 115 6.3.1 TOP APPLICANTS/OWNERS (COMPANIES) FOR BIOMATERIAL PATENTS, 2015–2025 115 6.3.2 LIST OF PATENTS 116 6.4 FUTURE APPLICATIONS 116 6.5 IMPACT OF AI/GEN AI ON BIOMATERIALS MARKET 116 6.5.1 TOP USE CASES AND MARKET POTENTIAL 117 6.5.2 CASE STUDIES OF AI IMPLEMENTATION 118 6.5.3 INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS 118 6.5.4 CLIENTS’ READINESS TO ADOPT GENERATIVE AI 118 7 SUSTAINABILITY AND REGULATORY LANDSCAPE 120 7.1 REGIONAL REGULATIONS & COMPLIANCE 120 7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 120 7.1.2 REGULATORY FRAMEWORK 123 7.1.3 INDUSTRY STANDARDS 125 7.2 SUSTAINABILITY IMPACT & REGULATORY POLICY INITIATIVES 125 7.3 CERTIFICATIONS, LABELING, AND ECO-STANDARDS 126 8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR 127 8.1 DECISION-MAKING PROCESS 127 8.2 BUYER STAKEHOLDERS & BUYING EVALUATION CRITERIA 127 8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS 127 8.2.2 KEY BUYING CRITERIA, BY END USER 128 8.3 ADOPTION BARRIERS & INTERNAL CHALLENGES 129 8.4 UNMET NEEDS FROM KEY END-USE INDUSTRIES 130 8.5 MARKET PROFITABILITY 130 9 BIOMATERIALS MARKET, BY TYPE 131 9.1 INTRODUCTION 132 9.2 METALLIC BIOMATERIALS 133 9.2.1 STAINLESS STEEL 134 9.2.1.1 Favorable mechanical properties, corrosion resistance, and cost-effectiveness to drive usage 134 9.2.2 TITANIUM & TITANIUM ALLOYS 135 9.2.2.1 Rising number of joint replacement procedures to aid market growth 135 9.2.3 COBALT-CHROME ALLOYS 136 9.2.3.1 Low cost and excellent corrosion resistance to augment market growth 136 9.2.4 SILVER 137 9.2.4.1 Toxic properties and low aesthetic to limit use of silver in biomaterial-based products 137 9.2.5 GOLD 138 9.2.5.1 Expanding applications of gold nanoparticles to drive demand for gold biomaterials 138 9.2.6 MAGNESIUM 139 9.2.6.1 Biodegradable characteristics of magnesium to aid segment growth 139 9.2.7 OTHER METALLIC BIOMATERIALS 139 9.3 POLYMERIC BIOMATERIALS 140 9.3.1 POLYMETHYLMETHACRYLATE (PMMA) 142 9.3.1.1 Long-standing clinical record demonstrating safety and biocompatibility to spur market growth 142 9.3.2 POLYETHYLENE 143 9.3.2.1 Wear and tear resistance of polyethylene to popularize usage in hip and knee joint replacements 143 9.3.3 POLYESTER 144 9.3.3.1 Biodegradable nature and biocompatibility to boost use in various medical applications 144 9.3.4 POLYVINYLCHLORIDE 145 9.3.4.1 Heavy chlorine content of polyvinylchloride to hamper market growth 145 9.3.5 SILICONE RUBBER 146 9.3.5.1 Non-reactive, stable, and resistant in extreme environments and temperatures to drive adoption of silicone rubber 146 9.3.6 NYLON 146 9.3.6.1 Low weight, corrosion resistance, and wide applications to propel market demand 146 9.3.7 POLYETHERETHERKETONE 147 9.3.7.1 Polyetheretherketone to gain popularity as viable alternative to metals 147 9.3.8 OTHER POLYMERIC BIOMATERIALS 148 9.4 CERAMIC BIOMATERIALS 148 9.4.1 CALCIUM PHOSPHATE 149 9.4.1.1 Close structural and chemical resemblance to natural bone and teeth to drive adoption in biomedical applications 149 9.4.2 ZIRCONIA 150 9.4.2.1 Bio-inertness and low wear rate of zirconia to boost market adoption 150 9.4.3 ALUMINUM OXIDE 151 9.4.3.1 Increasing use of aluminum oxide in hip replacements and dental implants to drive market 151 9.4.4 CALCIUM SULFATE 152 9.4.4.1 Better biocompatibility and bioresorbability to augment market adoption 152 9.4.5 CARBON 152 9.4.5.1 Increasing use of carbon nanofibers in regenerative medicine and cancer treatment to drive market growth 152 9.4.6 GLASS 153 9.4.6.1 Rising number of orthopedic and dental procedures to fuel demand for glass biomaterials 153 9.5 NATURAL BIOMATERIALS 154 9.5.1 HYALURONIC ACID 156 9.5.1.1 Rising incidences of osteoarthritis to drive hyaluronic acid biomaterials market 156 9.5.2 COLLAGEN 157 9.5.2.1 High tensile strength to be useful in plastic and cosmetic surgeries, cardiology, ophthalmology, and drug delivery 157 9.5.3 FIBRIN 157 9.5.3.1 Fibrin biomaterials to be useful in clinical practice for controlling bleeding and accelerating wound repair 157 9.5.4 CELLULOSE 158 9.5.4.1 Cellulose to be useful in wound healing, skin regeneration, and ophthalmology 158 9.5.5 CHITIN 159 9.5.5.1 Chitin to accelerate skin regeneration and possess high biocompatibility 159 9.5.6 ALGINATES 160 9.5.6.1 Use in wound healing, tissue engineering & regenerative medicine, and drug delivery to drive adoption 160 9.5.7 GELATIN 160 9.5.7.1 Low cost and comparable biocompatibility of gelatin to fuel market adoption 160 9.5.8 CHITOSAN 161 9.5.8.1 Non-toxicity of Chitosan to increase adoption in biomedical research 161 9.5.9 SILK 162 9.5.9.1 Flexibility and adhesive abilities to drive usage in wound healing applications 162 9.5.10 OTHER NATURAL BIOMATERIALS 163 10 BIOMATERIALS MARKET, BY APPLICATION 165 10.1 INTRODUCTION 166 10.2 ORTHOPEDIC 166 10.2.1 JOINT REPLACEMENT 167 10.2.1.1 Knee replacement 168 10.2.1.1.1 Rising count of knee replacement procedures globally to drive market growth 168 10.2.1.2 Hip replacement 169 10.2.1.2.1 Hip & knee joint replacements to be most commonly performed procedures 169 10.2.1.3 Shoulder replacement 170 10.2.1.3.1 Increasing shoulder surgeries to drive production of implants 170 10.2.1.4 Other joint replacement applications 171 10.2.2 BIORESORBABLE TISSUE FIXATION 171 10.2.2.1 Suture anchors 172 10.2.2.1.1 Growing awareness about suture anchor devices to propel market growth 172 10.2.2.2 Interference screws 173 10.2.2.2.1 Growing ACL reconstruction procedures to contribute to market growth 173 10.2.2.3 Meniscal repair tacks 174 10.2.2.3.1 Rising sports injuries to fuel growth in meniscal repair tacks market 174 10.2.2.4 Meshes 175 10.2.2.4.1 Wear resistance and proper shaping of bioresorbable implants to increase demand for bioresorbable meshes 175 10.2.3 SPINE SURGERIES 175 10.2.3.1 Spinal fusion 176 10.2.3.1.1 Introduction of minimally invasive spinal fusion procedures and better clinical outcomes to drive market growth 176 10.2.3.2 Minimally invasive fusion 177 10.2.3.2.1 Lesser post-surgery pain and faster recovery to drive demand for minimally invasive fusion procedures 177 10.2.3.3 Motion preservation & dynamic stabilization 178 10.2.3.3.1 Pedicle-based rod systems 179 10.2.3.3.1.1 Rising geriatric population to result in market growth 179 10.2.3.3.2 Interspinous spacers 180 10.2.3.3.2.1 High prevalence of degenerative spinal conditions to contribute to market growth 180 10.2.3.3.3 Artificial discs 180 10.2.3.3.3.1 High biocompatibility to increase usage in artificial discs 180 10.2.4 FRACTURE FIXATION DEVICES 181 10.2.4.1 Bone plates 182 10.2.4.1.1 High biocompatibility of biomaterials to be an integral component of bone plates 182 10.2.4.2 Screws 183 10.2.4.2.1 Metallic biomaterial screws to be extensively used in orthopedic procedures 183 10.2.4.3 Pins 183 10.2.4.3.1 Nonreactive nature of metallic biomaterial pins to favor usage in fracture fixation 183 10.2.4.4 Rods 184 10.2.4.4.1 High rigidity, easy mobility, and cost efficiency to make rods preferred for fracture fixation procedures 184 10.2.4.5 Wires 184 10.2.4.5.1 Wires made up of metallic biomaterials to help treat fractures of small bones 184 10.2.5 ORTHOBIOLOGICS 185 10.2.5.1 Rising cases of osteoarthritis to drive growth in viscosupplementation market 185 10.3 CARDIOVASCULAR 186 10.3.1 CATHETERS 187 10.3.1.1 Shift in patient preference from traditional open surgeries to minimally invasive surgeries to drive market 187 10.3.2 STENTS 188 10.3.2.1 Increasing number of coronary intervention procedures to boost demand for implantable stents 188 10.3.3 IMPLANTABLE CARDIAC DEFIBRILLATORS 189 10.3.3.1 Growing geriatric population and rising prevalence of chronic diseases to drive market 189 10.3.4 PACEMAKERS 190 10.3.4.1 High prevalence of bradycardia to aid demand for pacemakers 190 10.3.5 SENSORS 190 10.3.5.1 Increasing prevalence of cardiac disorders to boost demand for cardiovascular sensors 190 10.3.6 HEART VALVES 191 10.3.6.1 Growing geriatric population to increase demand for prosthetic valves 191 10.3.7 VASCULAR GRAFTS 192 10.3.7.1 Focus on research on use of biomaterials in vascular grafts to open opportunities for market growth 192 10.3.8 GUIDEWIRES 193 10.3.8.1 Guidewires to be used for guiding catheters and placing stents inside the heart 193 10.3.9 OTHER CARDIOVASCULAR APPLICATIONS 194 10.4 OPHTHALMOLOGY 194 10.4.1 CONTACT LENSES 195 10.4.1.1 Growing cases of refractive errors and preference for contact lenses over spectacles to drive market growth 195 10.4.2 INTRAOCULAR LENSES 196 10.4.2.1 Increasing prevalence of cataracts to boost number of cataract surgeries performed 196 10.4.3 FUNCTIONAL REPLACEMENT OF OCULAR TISSUES 197 10.4.3.1 Increasing funding and research activities for developing bionic eyes to propel segment growth 197 10.4.4 SYNTHETIC CORNEAS 198 10.4.4.1 Increasing number of corneal blindness cases globally to boost demand for synthetic collagen biomaterials 198 10.4.5 OTHER OPHTHALMOLOGY APPLICATIONS 198 10.5 DENTAL 199 10.5.1 DENTAL IMPLANTS 200 10.5.1.1 Rising awareness about dental health and increasing dental procedures to augment market growth 200 10.5.2 DENTAL BONE GRAFTS & SUBSTITUTES 201 10.5.2.1 Growing demand for dental implants during cosmetic dentistry to drive market 201 10.5.3 DENTAL MEMBRANES 202 10.5.3.1 Dental membranes in oral and periodontal surgery to prevent unwanted infections in oral cavity 202 10.5.4 TISSUE REGENERATION MATERIALS 202 10.5.4.1 Increasing prevalence of periodontal disease to augment market growth 202 10.6 PLASTIC SURGERY 203 10.6.1 SOFT TISSUE FILLERS 204 10.6.1.1 Long-lasting capacity and fewer allergic reactions to drive demand for soft-tissue fillers 204   10.6.2 CRANIOFACIAL SURGERY 205 10.6.2.1 Increasing incidence of trauma cases and head & neck cancer to augment market growth 205 10.6.3 FACIAL WRINKLE TREATMENT 206 10.6.3.1 Increase in demand for non-surgical cosmetic treatments to propel market growth 206 10.6.4 BIOENGINEERED SKINS 207 10.6.4.1 Increasing incidence of trauma cases and head & neck cancer to increase number of craniofacial surgeries 207 10.6.5 PERIPHERAL NERVE REPAIR 208 10.6.5.1 Increasing incidence of trauma cases to rise in peripheral nerve injuries 208 10.6.6 ACELLULAR DERMAL MATRICES 208 10.6.6.1 Ability to provide scaffold for tissue regeneration and reduce risk of immune rejection and adverse reactions to drive segment 208 10.7 WOUND HEALING 209 10.7.1 WOUND CLOSURE DEVICES 210 10.7.1.1 Sutures 211 10.7.1.1.1 Sutures to be used as advanced biologically active components for better drug delivery 211 10.7.1.2 Staples 212 10.7.1.2.1 Ease of placement and ability to shorten closure to augment segment growth 212 10.7.2 SURGICAL HEMOSTATS 213 10.7.2.1 Surgical hemostats to control bleeding and reduce frequent blood transfusions during surgical procedures 213 10.7.3 INTERNAL TISSUE SEALANTS 213 10.7.3.1 Increasing number of surgeries to drive use of internal tissue sealants 213 10.7.4 ADHESION BARRIERS 214 10.7.4.1 Focus on inflammatory healing process to drive adoption of adhesion barriers in surgical procedures 214 10.7.5 HERNIA MESHES 214 10.7.5.1 Polymeric biomaterial-based meshes to be used in hernia repair 214 10.7.6 SKIN SUBSTITUTES 215 10.7.6.1 Focus on prompting tissue regeneration and replacing damaged skin with functional tissue to aid market growth 215 10.8 TISSUE ENGINEERING 216 10.8.1 SCAFFOLDS FOR BIOMATERIALS 217 10.8.1.1 Rise in organ transplantation procedures to drive market 217 10.8.2 NANOMATERIALS FOR BIOSENSING 218 10.8.2.1 Rising research in nanotechnology to augment market growth 218 10.8.3 TAILORING OF INORGANIC NANOPARTICLES 218 10.8.3.1 Growing demand for nanotechnological medical products to drive market 218   10.9 NEUROLOGICAL/CENTRAL NERVOUS SYSTEM 219 10.9.1 SHUNTING SYSTEMS 220 10.9.1.1 Rising cases of hydrocephalus to boost market growth 220 10.9.2 CORTICAL NEURAL PROSTHETICS 221 10.9.2.1 Increased use of polymer-coated CNPs to treat paralyzed patients 221 10.9.3 HYDROGEL SCAFFOLDS FOR CNS REPAIR 222 10.9.3.1 Increasing incidence of spinal cord surgeries to drive demand for hydrogel scaffolds 222 10.9.4 NEURAL STEM CELL ENCAPSULATION 222 10.9.4.1 Lack of substitutes for neurotrauma treatment to boost market growth 222 10.10 URINARY 223 10.10.1 URINARY CATHETERS 224 10.10.1.1 Rise in implant-related cases of biofilm-associated infections to hinder market growth 224 10.10.2 URETHRAL STENTS 225 10.10.3 OTHER URINARY APPLICATIONS 225 10.11 OTHER APPLICATIONS 226 10.11.1 DRUG DELIVERY SYSTEMS 227 10.11.2 GASTROINTESTINAL APPLICATIONS 228 10.11.3 BARIATRIC SURGERY 229 11 BIOMATERIALS MARKET, BY END USER 230 11.1 INTRODUCTION 231 11.2 MEDICAL DEVICE MANUFACTURERS 231 11.2.1 DEMOGRAPHIC SHIFTS, TECHNOLOGICAL INNOVATION, AND EXPANDING CLINICAL APPLICATIONS TO DRIVE MARKET 231 11.3 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 232 11.3.1 INVESTMENT AND INNOVATION MOMENTUM IN PHARMA & BIOTECH TO ACCELERATE GLOBAL BIOMATERIAL ADOPTION 232 11.4 OTHER END USERS 233 12 BIOMATERIALS MARKET, BY REGION 235 12.1 INTRODUCTION 236 12.2 NORTH AMERICA 236 12.2.1 US 247 12.2.1.1 Rising incidence of cancer and ongoing research in developing biocompatible materials to drive market 247 12.2.2 CANADA 257 12.2.2.1 Growing incidence of cardiovascular diseases to propel market growth 257 12.3 EUROPE 266 12.3.1 GERMANY 276 12.3.1.1 Rising focus on clinical research and increasing number of patent approvals to aid market growth 276 12.3.2 UK 286 12.3.2.1 Increasing research activities and rising number of cardiovascular procedures to support market growth 286 12.3.3 FRANCE 295 12.3.3.1 Increased healthcare expenditure and structured regulatory framework to augment market growth 295 12.3.4 ITALY 304 12.3.4.1 Rising prevalence of neurological and cardiovascular disorders to boost market growth 304 12.3.5 SPAIN 314 12.3.5.1 Increased focus on research for biomaterial development to propel market growth 314 12.3.6 REST OF EUROPE 323 12.4 ASIA PACIFIC 333 12.4.1 CHINA 344 12.4.1.1 Lucrative medical devices industry and large geriatric population to drive market 344 12.4.2 JAPAN 353 12.4.2.1 Growing medical devices industry and rising focus on medical research to support market growth 353 12.4.3 INDIA 363 12.4.3.1 Large population base and high focus on medical tourism to aid market growth 363 12.4.4 SOUTH KOREA 373 12.4.4.1 High demand for healthcare services and advanced treatments to spur market growth 373 12.4.5 AUSTRALIA 382 12.4.5.1 Strategic public and sector-wide investments with clinical trial system reform to underpin biomedical research growth 382 12.4.6 REST OF ASIA PACIFIC 392 12.5 LATIN AMERICA 402 12.5.1 BRAZIL 412 12.5.1.1 Gradual increase in pharmaceutical R&D to fuel market growth 412 12.5.2 MEXICO 421 12.5.2.1 Rising number of cosmetic procedures to boost adoption of biomaterials 421 12.5.3 ARGENTINA 430 12.5.3.1 Increased incidence of cardiovascular diseases and favorable government healthcare system to aid market growth 430 12.5.4 REST OF LATIN AMERICA 440 12.6 MIDDLE EAST 450 12.6.1 GCC COUNTRIES 460 12.6.1.1 Kingdom of Saudi Arabia 470 12.6.1.1.1 Increasing prevalence of cardiovascular diseases to drive market 470   12.6.1.2 UAE 479 12.6.1.2.1 Strategic partnerships and regulatory alignment to drive global biomaterials market growth 479 12.6.1.3 Rest of GCC countries 488 12.6.2 REST OF MIDDLE EAST 498 12.7 AFRICA 508 12.7.1 EXPANSION IN HEALTHCARE INDUSTRY AND SUPPORTIVE REGULATORY POLICIES TO AID MARKET GROWTH 508 13 COMPETITIVE LANDSCAPE 518 13.1 INTRODUCTION 518 13.2 KEY STRATEGIES ADOPTED BY MAJOR PLAYERS 518 13.2.1 STRATEGIES ADOPTED BY KEY PLAYERS IN BIOMATERIALS MARKET 518 13.3 REVENUE ANALYSIS, 2023–2025 519 13.4 MARKET SHARE ANALYSIS, 2025 520 13.5 COMPANY EVALUATION MATRIX: KEY PLAYERS 522 13.5.1 STARS 522 13.5.2 EMERGING LEADERS 522 13.5.3 PERVASIVE PLAYERS 523 13.5.4 PARTICIPANTS 523 13.5.5 COMPETITIVE BENCHMARKING: KEY PLAYERS, 2025 524 13.5.5.1 Company footprint 524 13.5.5.2 Region footprint 525 13.5.5.3 Type footprint 526 13.5.5.4 Application footprint 527 13.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES 528 13.6.1 PROGRESSIVE COMPANIES 528 13.6.2 RESPONSIVE COMPANIES 528 13.6.3 DYNAMIC COMPANIES 528 13.6.4 STARTING BLOCKS 528 13.6.5 COMPETITIVE BENCHMARKING OF STARTUPS/SMES 530 13.6.5.1 List of key startups/SMEs 530 13.6.5.2 Competitive benchmarking of key startups/SMEs 531 13.7 COMPANY VALUATION & FINANCIAL METRICS 531 13.7.1 FINANCIAL METRICS 531 13.7.2 COMPANY VALUATION 532 13.8 BRAND/PRODUCT COMPARATIVE ANALYSIS 533 13.9 COMPETITIVE SCENARIO 533 13.9.1 PRODUCT LAUNCHES 534 13.9.2 DEALS 534 13.9.3 EXPANSIONS 535   14 COMPANY PROFILES 536 14.1 KEY PLAYERS 536 14.1.1 BASF SE 536 14.1.1.1 Business overview 536 14.1.1.2 Products/Services/Solutions offered 537 14.1.1.3 Recent developments 538 14.1.1.3.1 Deals 538 14.1.1.3.2 Other developments 539 14.1.1.4 MnM view 539 14.1.1.4.1 Right to win 539 14.1.1.4.2 Strategic choices 539 14.1.1.4.3 Weaknesses & competitive threats 539 14.1.2 COVESTRO AG 540 14.1.2.1 Business overview 540 14.1.2.2 Products/Services/Solutions offered 541 14.1.2.3 Recent developments 543 14.1.2.3.1 Product launches 543 14.1.2.3.2 Deals 543 14.1.2.3.3 Expansions 543 14.1.2.3.4 Other developments 544 14.1.2.4 MnM view 544 14.1.2.4.1 Right to win 544 14.1.2.4.2 Strategic choices 544 14.1.2.4.3 Weaknesses & competitive threats 544 14.1.3 CELANESE CORPORATION 545 14.1.3.1 Business overview 545 14.1.3.2 Products/Services/Solutions offered 546 14.1.3.3 Recent developments 548 14.1.3.3.1 Deals 548 14.1.3.4 MnM view 548 14.1.3.4.1 Right to win 548 14.1.3.4.2 Strategic choices 548 14.1.3.4.3 Weaknesses & competitive threats 549 14.1.4 CARPENTER TECHNOLOGY CORPORATION 550 14.1.4.1 Business overview 550 14.1.4.2 Products/Services/Solutions offered 551 14.1.4.2.1 Other developments 552 14.1.4.3 MnM view 553 14.1.4.3.1 Right to win 553 14.1.4.3.2 Strategic choices 553 14.1.4.3.3 Weaknesses & competitive threats 553   14.1.5 EVONIK INDUSTRIES AG 554 14.1.5.1 Business overview 554 14.1.5.2 Products/Services/Solutions offered 555 14.1.5.3 Recent developments 558 14.1.5.3.1 Product launches 558 14.1.5.3.2 Deals 558 14.1.5.4 MnM view 559 14.1.5.4.1 Right to win 559 14.1.5.4.2 Strategic choices 559 14.1.5.4.3 Weaknesses & competitive threats 559 14.1.6 DSM 560 14.1.6.1 Business overview 560 14.1.6.2 Products/Services/Solutions offered 561 14.1.6.3 Recent developments 563 14.1.6.3.1 Deals 563 14.1.6.3.2 Expansions 564 14.1.7 CORBION NV 565 14.1.7.1 Business overview 565 14.1.7.2 Products/Services/Solutions offered 566 14.1.7.3 Recent developments 568 14.1.7.3.1 Expansions 568 14.1.8 VICTREX PLC 569 14.1.8.1 Business overview 569 14.1.8.2 Products/Services/Solutions offered 570 14.1.8.3 Recent developments 571 14.1.8.3.1 Product launches 571 14.1.8.3.2 Expansions 571 14.1.9 MITSUBISHI CHEMICAL CORPORATION 572 14.1.9.1 Business overview 572 14.1.9.2 Products/Services/Solutions offered 573 14.1.10 COORSTEK INC. 574 14.1.10.1 Business overview 574 14.1.10.2 Products/Services/Solutions offered 574 14.1.11 BERKELEY ADVANCED BIOMATERIALS 575 14.1.11.1 Business overview 575 14.1.11.2 Products/Services/Solutions offered 575 14.1.12 CAM BIOCERAMICS B.V. 577 14.1.12.1 Business overview 577 14.1.12.2 Products/Services/Solutions offered 577 14.1.12.3 Recent developments 578 14.1.12.3.1 Deals 578   14.1.13 ZEUS COMPANY INC. 579 14.1.13.1 Business overview 579 14.1.13.2 Products/Services/Solutions offered 579 14.1.13.3 Recent developments 581 14.1.13.3.1 Product launches 581 14.1.13.3.2 Expansions 581 14.1.14 AMETEK INC. 582 14.1.14.1 Business overview 582 14.1.14.2 Products/Services/Solutions offered 583 14.1.14.3 Recent developments 583 14.1.14.3.1 Deals 583 14.1.14.3.2 Expansions 584 14.1.15 GELITA AG 585 14.1.15.1 Business overview 585 14.1.15.2 Products/Services/Solutions offered 585 14.1.15.3 Recent developments 587 14.1.15.3.1 Product launches 587 14.2 OTHER PLAYERS 588 14.2.1 COLLAGEN SOLUTIONS (US) LLC) 588 14.2.2 BIOCOMPOSITES 589 14.2.3 NOBLE BIOMATERIALS, INC. 590 14.2.4 REGENITY 590 14.2.5 KURARAY CO., LTD. 591 14.2.6 SOLESIS 593 14.2.7 INSTITUT STRAUMANN AG 594 14.2.8 FOSTER CORPORATION 595 14.2.9 CDI PRODUCTS 596 14.2.10 REVBIO, INC. 597 15 RESEARCH METHODOLOGY 598 15.1 RESEARCH DATA 598 15.1.1 SECONDARY DATA 599 15.1.1.1 Key objectives of secondary research 599 15.1.2 PRIMARY DATA 599 15.1.2.1 Breakdown of primaries 600 15.1.2.2 Key objectives of primary research 600 15.2 MARKET ESTIMATION METHODOLOGY 601 15.3 MARKET SIZE ESTIMATION 601 15.3.1 COMPANY REVENUE ANALYSIS (BOTTOM-UP APPROACH) 601 15.3.2 MNM REPOSITORY ANALYSIS 603 15.3.3 PRIMARY INTERVIEWS 603 15.3.4 INSIGHTS OF PRIMARY EXPERTS 603 15.3.5 TOP-DOWN APPROACH 604 15.4 MARKET GROWTH RATE PROJECTIONS 605 15.5 DATA TRIANGULATION 607 15.6 STUDY ASSUMPTIONS 608 15.7 RESEARCH LIMITATIONS 608 15.8 RISK ANALYSIS 609 16 APPENDIX 610 16.1 DISCUSSION GUIDE 610 16.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 615 16.3 CUSTOMIZATION OPTIONS 617 16.4 RELATED REPORTS 617 16.5 AUTHOR DETAILS 618
圖表清單 List of Tables & Figures
TABLE 1 BIOMATERIALS MARKET: INCLUSIONS & EXCLUSIONS 58 TABLE 2 IMPACT ANALYSIS OF FACTORS IN BIOMATERIALS MARKET 72 TABLE 3 IMPACT OF PORTER’S FIVE FORCES ON BIOMATERIALS MARKET 80 TABLE 4 ROLE OF KEY COMPANIES (DEMAND/SUPPLY SIDES) IN BIOMATERIALS MARKET ECOSYSTEM 85 TABLE 5 INDICATIVE SELLING PRICE OF BIOMATERIALS, BY KEY PLAYER, 2025 (USD) 86 TABLE 6 INDICATIVE SELLING PRICE OF BIOMATERIALS, BY REGION, 2025 (USD) 87 TABLE 7 IMPORT DATA FOR HS CODE 7221 (STAINLESS STEEL), BY COUNTRY, 2021–2025 (USD THOUSAND) 88 TABLE 8 EXPORT DATA FOR HS CODE 7221 (STAINLESS STEEL), BY COUNTRY, 2021–2025 (USD THOUSAND) 89 TABLE 9 IMPORT VOLUME FOR HS CODE 7221 (STAINLESS STEEL), BY COUNTRY, 2021–2025 (TONS) 90 TABLE 10 EXPORT VOLUME FOR HS CODE 7221 (STAINLESS STEEL), BY COUNTRY, 2021–2025 (TONS) 91 TABLE 11 IMPORT DATA FOR HS CODE 284329 (SILVER), BY COUNTRY, 2021–2025 (USD THOUSAND) 92 TABLE 12 EXPORT DATA FOR HS CODE 284329 (SILVER), BY COUNTRY, 2021–2025 (USD THOUSAND) 93 TABLE 13 IMPORT VOLUME FOR HS CODE 284329 (SILVER), BY COUNTRY, 2021–2025 (TONS) 94 TABLE 14 EXPORT VOLUME FOR HS CODE 284329 (SILVER), BY COUNTRY, 2021–2025 (TONS) 95 TABLE 15 IMPORT DATA FOR HS CODE 281820 (ALUMINUM OXIDE), BY COUNTRY, 2021–2025 (USD THOUSAND) 96 TABLE 16 EXPORT DATA FOR HS CODE 281820 (ALUMINUM OXIDE), BY COUNTRY, 2021–2025 (USD THOUSAND) 97 TABLE 17 IMPORT VOLUME FOR HS CODE 281820 (ALUMINUM OXIDE), BY COUNTRY, 2021–2025 (TONS) 98 TABLE 18 EXPORT VOLUME FOR HS CODE 281820 (ALUMINUM OXIDE), BY COUNTRY, 2021–2025 (TONS) 99 TABLE 19 IMPORT DATA FOR HS CODE 3910 (SILICONE), BY COUNTRY, 2021–2025 (USD THOUSAND) 100 TABLE 20 EXPORT DATA FOR HS CODE 3910 (SILICONE), BY COUNTRY, 2021–2025 (USD THOUSAND) 101 TABLE 21 IMPORT VOLUME FOR HS CODE 3910 (SILICONE), BY COUNTRY, 2021–2025 (TONS) 102 TABLE 22 EXPORT VOLUME FOR HS CODE 3910, BY COUNTRY, 2021–2025 (TONS) 103 TABLE 23 KEY CONFERENCES & EVENTS IN BIOMATERIALS MARKET, JANUARY 2026–DECEMBER 2027 104 TABLE 24 CASE STUDY 1: SCALING MEDICAL-GRADE POLYMER SUPPLY THROUGH INTEGRATED VERBUND MANUFACTURING 106 TABLE 25 CASE STUDY 2: STRENGTHENING HIGH-PERFORMANCE POLYMER PLATFORMS FOR REGULATED BIOMATERIALS APPLICATIONS 107 TABLE 26 CASE STUDY 3: ADVANCING BIORESORBABLE AND BIOCOMPATIBLE MATERIALS FOR CLINICAL AND COMMERCIAL SCALE-UP 107 TABLE 27 US-ADJUSTED RECIPROCAL TARIFF RATES 108 TABLE 28 INDICATIVE LIST OF PATENTS IN BIOMATERIALS MARKET, 2025 116 TABLE 29 CASE STUDIES OF AI IMPLEMENTATION IN BIOMATERIALS MARKET 118 TABLE 30 CLIENT’S READINESS TO ADOPT GENERATIVE AI IN BIOMATERIALS MARKET 119 TABLE 31 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 121 TABLE 32 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 121 TABLE 33 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 122 TABLE 34 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 123 TABLE 35 COUNTRY-WISE REGULATORY SCENARIO FOR BIOMATERIAL MANUFACTURERS 124 TABLE 36 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS, BY TYPE (%) 128 TABLE 37 KEY BUYING CRITERIA, BY END USER 128 TABLE 38 IMPORTANT PROPERTIES OF BIOMATERIALS, BY APPLICATION 132 TABLE 39 BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 133 TABLE 40 METALLIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 133 TABLE 41 METALLIC BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION) 134 TABLE 42 STAINLESS STEEL BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION) 135 TABLE 43 TITANIUM & TITANIUM ALLOY BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION) 136 TABLE 44 COBALT-CHROME ALLOY BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION) 137 TABLE 45 SILVER BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION) 138 TABLE 46 GOLD BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION) 138 TABLE 47 MAGNESIUM BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION) 139 TABLE 48 OTHER METALLIC BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION) 140 TABLE 49 APPLICATIONS OF SYNTHETIC POLYMERS 141 TABLE 50 POLYMERIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 141 TABLE 51 POLYMERIC BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION) 142 TABLE 52 POLYMETHYLMETHACRYLATE (PMMA) BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION) 143 TABLE 53 POLYETHYLENE BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION) 144 TABLE 54 POLYESTER BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION) 145 TABLE 55 POLYVINYLCHLORIDE BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION) 145 TABLE 56 SILICONE RUBBER BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION) 146 TABLE 57 NYLON BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION) 147 TABLE 58 POLYETHERETHERKETONE (PEEK) BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION) 148 TABLE 59 OTHER POLYMERIC BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION) 148 TABLE 60 CERAMIC BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION) 149 TABLE 61 CERAMIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 149 TABLE 62 CALCIUM PHOSPHATE BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION) 150 TABLE 63 ZIRCONIA BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION) 151 TABLE 64 ALUMINUM OXIDE BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION) 151 TABLE 65 CALCIUM SULFATE BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION) 152 TABLE 66 CARBON BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION) 153 TABLE 67 GLASS BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION) 154 TABLE 68 APPLICATIONS OF NATURAL BIOMATERIALS 154 TABLE 69 NATURAL BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 155 TABLE 70 NATURAL BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION) 156 TABLE 71 HYALURONIC ACID BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION) 156 TABLE 72 COLLAGEN BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION) 157 TABLE 73 FIBRIN BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION) 158 TABLE 74 CELLULOSE BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION) 159 TABLE 75 CHITIN BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION) 159 TABLE 76 ALGINATES BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION) 160 TABLE 77 GELATIN BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION) 161 TABLE 78 CHITOSAN BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION) 162 TABLE 79 SILK BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION) 163 TABLE 80 OTHER NATURAL BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION) 164 TABLE 81 BIOMATERIALS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 166 TABLE 82 BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 167 TABLE 83 BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY REGION, 2024–2031 (USD MILLION) 167 TABLE 84 JOINT REPLACEMENT BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 168 TABLE 85 JOINT REPLACEMENT BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION) 168 TABLE 86 KNEE REPLACEMENT BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION) 169 TABLE 87 HIP REPLACEMENT BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION) 170 TABLE 88 SHOULDER REPLACEMENT BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION) 170 TABLE 89 OTHER JOINT REPLACEMENT BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION) 171 TABLE 90 BIORESORBABLE BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 172 TABLE 91 BIORESORBABLE BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION) 172 TABLE 92 SUTURE ANCHOR BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION) 173 TABLE 93 INTERFERENCE SCREW BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION) 174 TABLE 94 MENISCAL REPAIR TACK BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION) 174 TABLE 95 MESH BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION) 175 TABLE 96 BIOMATERIALS MARKET FOR SPINE SURGERIES, BY TYPE, 2024–2031 (USD MILLION) 176 TABLE 97 BIOMATERIALS MARKET FOR SPINE SURGERIES, BY REGION, 2024–2031 (USD MILLION) 176 TABLE 98 SPINAL FUSION BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION) 177 TABLE 99 MINIMALLY INVASIVE FUSION BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION) 178 TABLE 100 BIOMATERIALS MARKET FOR MOTION PRESERVATION & DYNAMIC STABILIZATION, BY TYPE, 2024–2031 (USD MILLION) 178 TABLE 101 MOTION PRESERVATION & DYNAMIC STABILIZATION BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION) 179 TABLE 102 PEDICLE-BASED ROD SYSTEM BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION) 179 TABLE 103 INTERSPINOUS SPACER BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION) 180 TABLE 104 ARTIFICIAL DISC BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION) 181 TABLE 105 BIOMATERIALS MARKET FOR FRACTURE FIXATION, BY TYPE, 2024–2031 (USD MILLION) 181 TABLE 106 FRACTURE FIXATION BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION) 182 TABLE 107 BONE PLATE BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION) 182 TABLE 108 SCREW BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION) 183 TABLE 109 PIN BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION) 184 TABLE 110 ROD BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION) 184 TABLE 111 WIRE BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION) 185 TABLE 112 ORTHOBIOLOGICS BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION) 186 TABLE 113 BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 187 TABLE 114 BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY REGION, 2024–2031 (USD MILLION) 187 TABLE 115 CATHETER BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION) 188 TABLE 116 STENT BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION) 189 TABLE 117 IMPLANTABLE CARDIAC DEFIBRILLATOR BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION) 189 TABLE 118 PACEMAKER BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION) 190 TABLE 119 SENSOR BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION) 191 TABLE 120 BIOMATERIALS USED FOR DIFFERENT VALVE COMPONENTS 191 TABLE 121 HEART VALVE BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION) 192 TABLE 122 VASCULAR GRAFT BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION) 193 TABLE 123 GUIDEWIRE BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION) 193 TABLE 124 OTHER CARDIOVASCULAR BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION) 194 TABLE 125 BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 195 TABLE 126 BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY REGION, 2024–2031 (USD MILLION) 195 TABLE 127 CONTACT LENSE BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION) 196 TABLE 128 INTRAOCULAR LENSE BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION) 197 TABLE 129 FUNCTIONAL REPLACEMENTS OF OCULAR TISSUE BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION) 197 TABLE 130 SYNTHETIC CORNEA BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION) 198 TABLE 131 OTHER OPHTHALMOLOGY BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION) 199 TABLE 132 BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 199 TABLE 133 BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY REGION, 2024–2031 (USD MILLION) 200 TABLE 134 DENTAL IMPLANT BIOMAERIALS MARKET, BY REGION, 2024–2031 (USD MILLION) 201 TABLE 135 DENTAL BONE GRAFT & SUBSTITUTE BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION) 201 TABLE 136 DENTAL MEMBRANE BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION) 202 TABLE 137 TISSUE REGENERATION BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION) 203 TABLE 138 BIOMATERIALS MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 203 TABLE 139 BIOMATERIALS MARKET FOR PLASTIC SURGERY APPLICATIONS, BY REGION, 2024–2031 (USD MILLION) 204 TABLE 140 SOFT TISSUE FILLERS BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION) 205 TABLE 141 CRANIOFACIAL SURGERY BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION) 206 TABLE 142 FACIAL WRINKLE TREATMENT BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION) 207 TABLE 143 BIOENGINEERED SKIN BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION) 207 TABLE 144 PERIPHERAL NERVE REPAIR BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION) 208 TABLE 145 ACELLULAR DERMAL MATRICE BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION) 209 TABLE 146 BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 209 TABLE 147 BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY REGION, 2024–2031 (USD MILLION) 210 TABLE 148 WOUND CLOSURE DEVICE BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 210 TABLE 149 WOUND CLOSURE DEVICE BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION) 211 TABLE 150 SUTURE BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION) 212 TABLE 151 STAPLE BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION) 212 TABLE 152 SURGICAL HEMOSTAT BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION) 213 TABLE 153 INTERNAL TISSUE SEALANT BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION) 214 TABLE 154 ADHESION BARRIER BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION) 214 TABLE 155 HERNIA MESH BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION) 215 TABLE 156 SKIN SUBSTITUTE BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION) 216 TABLE 157 BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 216 TABLE 158 BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY REGION, 2024–2031 (USD MILLION) 217 TABLE 159 SCAFFOLDS FOR BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION) 217 TABLE 160 NANOMATERIALS FOR BIOSENSING BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION) 218 TABLE 161 TAILORING OF INORGANIC NANOPARTICLE BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION) 219 TABLE 162 BIOMATERIALS MARKET FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 219 TABLE 163 BIOMATERIALS MARKET FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS,BY REGION, 2024–2031 (USD MILLION) 220 TABLE 164 SHUNTING SYSTEM BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION) 221 TABLE 165 CORTICAL NEURAL PROSTHETIC BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION) 221 TABLE 166 HYDROGEL SCAFFOLD FOR CNS REPAIR BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION) 222 TABLE 167 NEURAL STEM CELL ENCAPSULATION BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION) 223 TABLE 168 BIOMATERIALS MARKET FOR URINARY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 223 TABLE 169 BIOMATERIALS MARKET FOR URINARY APPLICATIONS, BY REGION, 2024–2031 (USD MILLION) 224 TABLE 170 URINARY CATHETER BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION) 225 TABLE 171 URETHRAL STENT BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION) 225 TABLE 172 OTHER URINARY BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION) 226 TABLE 173 BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 226 TABLE 174 BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY REGION, 2024–2031 (USD MILLION) 227 TABLE 175 DRUG DELIVERY SYSTEM BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION) 228 TABLE 176 GASTROINTESTINAL APPLICATION BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION) 228 TABLE 177 BARIATRIC SURGERY BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION) 229 TABLE 178 BIOMATERIALS MARKET, BY END USER, 2024–2031 (USD MILLION) 231 TABLE 179 BIOMATERIALS MARKET FOR MEDICAL DEVICE MANUFACTURERS, BY REGION, 2024–2031(USD MILLION) 232 TABLE 180 BIOMATERIALS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024–2031 (USD MILLION) 233 TABLE 181 BIOMATERIALS MARKET FOR OTHER END USERS, BY REGION, 2024–2031 (USD MILLION) 234 TABLE 182 BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION) 236 TABLE 183 NORTH AMERICA: BIOMATERIALS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 237 TABLE 184 NORTH AMERICA: BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 238 TABLE 185 NORTH AMERICA: METALLIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 238 TABLE 186 NORTH AMERICA: CERAMIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 238 TABLE 187 NORTH AMERICA: POLYMERIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 239 TABLE 188 NORTH AMERICA: NATURAL BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 239 TABLE 189 NORTH AMERICA: BIOMATERIALS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 240 TABLE 190 NORTH AMERICA: BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 240 TABLE 191 NORTH AMERICA: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 241 TABLE 192 NORTH AMERICA: JOINT REPLACEMENT BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 241 TABLE 193 NORTH AMERICA: SPINE SURGERY BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 241 TABLE 194 NORTH AMERICA: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2024–2031 (USD MILLION) 242 TABLE 195 NORTH AMERICA: BIORESORBABLE TISSUE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 242 TABLE 196 NORTH AMERICA: FRACTURE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 242 TABLE 197 NORTH AMERICA: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 243 TABLE 198 NORTH AMERICA: BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 243 TABLE 199 NORTH AMERICA: BIOMATERIALS MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 244 TABLE 200 NORTH AMERICA: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 244 TABLE 201 NORTH AMERICA: WOUND CLOSURE DEVICE BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 245 TABLE 202 NORTH AMERICA: BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 245 TABLE 203 NORTH AMERICA: BIOMATERIALS MARKET FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 245 TABLE 204 NORTH AMERICA: BIOMATERIALS MARKET FOR URINARY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 246 TABLE 205 NORTH AMERICA: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 246 TABLE 206 NORTH AMERICA: BIOMATERIALS MARKET, BY END USER, 2024–2031 (USD MILLION) 246 TABLE 207 US: BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 247 TABLE 208 US: METALLIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 248 TABLE 209 US: CERAMIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 248 TABLE 210 US: POLYMERIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 249 TABLE 211 US: NATURAL BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 249 TABLE 212 US: BIOMATERIALS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 250 TABLE 213 US: BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 250 TABLE 214 US: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 251 TABLE 215 US: JOINT REPLACEMENT BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 251 TABLE 216 US: SPINE SURGERY BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 251 TABLE 217 US: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2024–2031 (USD MILLION) 252 TABLE 218 US: BIORESORBABLE TISSUE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 252 TABLE 219 US: FRACTURE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 252 TABLE 220 US: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 253 TABLE 221 US: BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 253 TABLE 222 US: BIOMATERIALS MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 254 TABLE 223 US: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 254 TABLE 224 US: WOUND CLOSURE DEVICE BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 255 TABLE 225 US: BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 255 TABLE 226 US: BIOMATERIALS MARKET FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 255 TABLE 227 US: BIOMATERIALS MARKET FOR URINARY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 256 TABLE 228 US: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 256 TABLE 229 US: BIOMATERIALS MARKET, BY END USER, 2024–2031 (USD MILLION) 256 TABLE 230 CANADA: BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 257 TABLE 231 CANADA: METALLIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 257 TABLE 232 CANADA: CERAMIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 258 TABLE 233 CANADA: POLYMERIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 258 TABLE 234 CANADA: NATURAL BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 259 TABLE 235 CANADA: BIOMATERIALS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 259 TABLE 236 CANADA: BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 260 TABLE 237 CANADA: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 260 TABLE 238 CANADA: JOINT REPLACEMENT BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 261 TABLE 239 CANADA: SPINE SURGERY BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 261 TABLE 240 CANADA: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2024–2031 (USD MILLION) 261 TABLE 241 CANADA: BIORESORBABLE TISSUE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 262 TABLE 242 CANADA: FRACTURE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 262 TABLE 243 CANADA: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 262 TABLE 244 CANADA: BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 263 TABLE 245 CANADA: BIOMATERIALS MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 263 TABLE 246 CANADA: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 264 TABLE 247 CANADA: WOUND CLOSURE DEVICE BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 264 TABLE 248 CANADA: BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 264 TABLE 249 CANADA: BIOMATERIALS MARKET FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 265 TABLE 250 CANADA: BIOMATERIALS MARKET FOR URINARY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 265 TABLE 251 CANADA: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 265 TABLE 252 CANADA: BIOMATERIALS MARKET, BY END USER, 2024–2031 (USD MILLION) 266 TABLE 253 EUROPE: BIOMATERIALS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 266 TABLE 254 EUROPE: BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 267 TABLE 255 EUROPE: METALLIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 267 TABLE 256 EUROPE: CERAMIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 267 TABLE 257 EUROPE: POLYMERIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 268 TABLE 258 EUROPE: NATURAL BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 268 TABLE 259 EUROPE: BIOMATERIALS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 269 TABLE 260 EUROPE: BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 269 TABLE 261 EUROPE: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 270 TABLE 262 EUROPE: JOINT REPLACEMENT BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 270 TABLE 263 EUROPE: SPINE SURGERY BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 270 TABLE 264 EUROPE: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2024–2031 (USD MILLION) 271 TABLE 265 EUROPE: BIORESORBABLE TISSUE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 271 TABLE 266 EUROPE: FRACTURE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 271 TABLE 267 EUROPE: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 272 TABLE 268 EUROPE: BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 272 TABLE 269 EUROPE: BIOMATERIALS MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 273 TABLE 270 EUROPE: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 273 TABLE 271 EUROPE: WOUND CLOSURE DEVICE BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 274 TABLE 272 EUROPE: BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 274 TABLE 273 EUROPE: BIOMATERIALS MARKET FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 274 TABLE 274 EUROPE: BIOMATERIALS MARKET FOR URINARY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 275 TABLE 275 EUROPE: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 275 TABLE 276 EUROPE: BIOMATERIALS MARKET, BY END USER, 2024–2031 (USD MILLION) 275 TABLE 277 GERMANY: BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 276 TABLE 278 GERMANY: METALLIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 277 TABLE 279 GERMANY: CERAMIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 277 TABLE 280 GERMANY: POLYMERIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 278 TABLE 281 GERMANY: NATURAL BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 278 TABLE 282 GERMANY: BIOMATERIALS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 279 TABLE 283 GERMANY: BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 279 TABLE 284 GERMANY: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 280 TABLE 285 GERMANY: JOINT REPLACEMENT BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 280 TABLE 286 GERMANY: SPINE SURGERY BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 280 TABLE 287 GERMANY: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2024–2031 (USD MILLION) 281 TABLE 288 GERMANY: BIORESORBABLE TISSUE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 281 TABLE 289 GERMANY: FRACTURE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 281 TABLE 290 GERMANY: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 282 TABLE 291 GERMANY: BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 282 TABLE 292 GERMANY: BIOMATERIALS MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 283 TABLE 293 GERMANY: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 283 TABLE 294 GERMANY: WOUND CLOSURE DEVICE BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 284 TABLE 295 GERMANY: BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 284 TABLE 296 GERMANY: BIOMATERIALS MARKET FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 284 TABLE 297 GERMANY: BIOMATERIALS MARKET FOR URINARY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 285 TABLE 298 GERMANY: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 285 TABLE 299 GERMANY: BIOMATERIALS MARKET, BY END USER, 2024–2031 (USD MILLION) 285 TABLE 300 UK: BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 286 TABLE 301 UK: METALLIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 286 TABLE 302 UK: CERAMIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 287 TABLE 303 UK: POLYMERIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 287 TABLE 304 UK: NATURAL BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 288 TABLE 305 UK: BIOMATERIALS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 288 TABLE 306 UK: BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 289 TABLE 307 UK: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 289 TABLE 308 UK: JOINT REPLACEMENT BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 290 TABLE 309 UK: SPINE SURGERY BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 290 TABLE 310 UK: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2024–2031 (USD MILLION) 290 TABLE 311 UK: BIORESORBABLE TISSUE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 291 TABLE 312 UK: FRACTURE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 291 TABLE 313 UK: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 291 TABLE 314 UK: BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 292 TABLE 315 UK: BIOMATERIALS MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 292 TABLE 316 UK: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 293 TABLE 317 UK: WOUND CLOSURE DEVICE BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 293 TABLE 318 UK: BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 293 TABLE 319 UK: BIOMATERIALS MARKET FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 294 TABLE 320 UK: BIOMATERIALS MARKET FOR URINARY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 294 TABLE 321 UK: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 294 TABLE 322 UK: BIOMATERIALS MARKET, BY END USER, 2024–2031 (USD MILLION) 295 TABLE 323 FRANCE: BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 295 TABLE 324 FRANCE: METALLIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 296 TABLE 325 FRANCE: CERAMIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 296 TABLE 326 FRANCE: POLYMERIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 297 TABLE 327 FRANCE: NATURAL BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 297 TABLE 328 FRANCE: BIOMATERIALS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 298 TABLE 329 FRANCE: BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 298 TABLE 330 FRANCE: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 299 TABLE 331 FRANCE: JOINT REPLACEMENT BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 299 TABLE 332 FRANCE: SPINE SURGERY BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 299 TABLE 333 FRANCE: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2024–2031 (USD MILLION) 300 TABLE 334 FRANCE: BIORESORBABLE TISSUE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 300 TABLE 335 FRANCE: FRACTURE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 300 TABLE 336 FRANCE: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 301 TABLE 337 FRANCE: BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 301 TABLE 338 FRANCE: BIOMATERIALS MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 302 TABLE 339 FRANCE: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 302 TABLE 340 FRANCE: WOUND CLOSURE DEVICE BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 303 TABLE 341 FRANCE: BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 303 TABLE 342 FRANCE: BIOMATERIALS MARKET FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 303 TABLE 343 FRANCE: BIOMATERIALS MARKET FOR URINARY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 304 TABLE 344 FRANCE: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 304 TABLE 345 FRANCE: BIOMATERIALS MARKET, BY END USER, 2024–2031 (USD MILLION) 304 TABLE 346 ITALY: BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 305 TABLE 347 ITALY: METALLIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 305 TABLE 348 ITALY: CERAMIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 306 TABLE 349 ITALY: POLYMERIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 306 TABLE 350 ITALY: NATURAL BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 307 TABLE 351 ITALY: BIOMATERIALS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 307 TABLE 352 ITALY: BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 308 TABLE 353 ITALY: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 308 TABLE 354 ITALY: JOINT REPLACEMENT BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 309 TABLE 355 ITALY: SPINE SURGERY BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 309 TABLE 356 ITALY: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2024–2031 (USD MILLION) 309 TABLE 357 ITALY: BIORESORBABLE TISSUE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 310 TABLE 358 ITALY: FRACTURE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 310 TABLE 359 ITALY: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 310 TABLE 360 ITALY: BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 311 TABLE 361 ITALY: BIOMATERIALS MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 311 TABLE 362 ITALY: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 312 TABLE 363 ITALY: WOUND CLOSURE DEVICE BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 312 TABLE 364 ITALY: BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 312 TABLE 365 ITALY: BIOMATERIALS MARKET FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 313 TABLE 366 ITALY: BIOMATERIALS MARKET FOR URINARY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 313 TABLE 367 ITALY: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 313 TABLE 368 ITALY: BIOMATERIALS MARKET, BY END USER, 2024–2031 (USD MILLION) 314 TABLE 369 SPAIN: BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 314 TABLE 370 SPAIN: METALLIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 315 TABLE 371 SPAIN: CERAMIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 315 TABLE 372 SPAIN: POLYMERIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 316 TABLE 373 SPAIN: NATURAL BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 316 TABLE 374 SPAIN: BIOMATERIALS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 317 TABLE 375 SPAIN: BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 317 TABLE 376 SPAIN: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 318 TABLE 377 SPAIN: JOINT REPLACEMENT BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 318 TABLE 378 SPAIN: SPINE SURGERY BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 318 TABLE 379 SPAIN: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2024–2031 (USD MILLION) 319 TABLE 380 SPAIN: BIORESORBABLE TISSUE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 319 TABLE 381 SPAIN: FRACTURE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 319 TABLE 382 SPAIN: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 320 TABLE 383 SPAIN: BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 320 TABLE 384 SPAIN: BIOMATERIALS MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 321 TABLE 385 SPAIN: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 321 TABLE 386 SPAIN: WOUND CLOSURE DEVICE BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 322 TABLE 387 SPAIN: BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 322 TABLE 388 SPAIN: BIOMATERIALS MARKET FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 322 TABLE 389 SPAIN: BIOMATERIALS MARKET FOR URINARY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 323 TABLE 390 SPAIN: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 323 TABLE 391 SPAIN: BIOMATERIALS MARKET, BY END USER, 2024–2031 (USD MILLION) 323 TABLE 392 REST OF EUROPE: BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 324 TABLE 393 REST OF EUROPE: METALLIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 324 TABLE 394 REST OF EUROPE: CERAMIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 325 TABLE 395 REST OF EUROPE: POLYMERIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 325 TABLE 396 REST OF EUROPE: NATURAL BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 326 TABLE 397 REST OF EUROPE: BIOMATERIALS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 326 TABLE 398 REST OF EUROPE: BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 327 TABLE 399 REST OF EUROPE: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 327 TABLE 400 REST OF EUROPE: JOINT REPLACEMENT BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 328 TABLE 401 REST OF EUROPE: SPINE SURGERY BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 328 TABLE 402 REST OF EUROPE: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2024–2031 (USD MILLION) 328 TABLE 403 REST OF EUROPE: BIORESORBABLE TISSUE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 329 TABLE 404 REST OF EUROPE: FRACTURE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 329 TABLE 405 REST OF EUROPE: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 329 TABLE 406 REST OF EUROPE: BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 330 TABLE 407 REST OF EUROPE: BIOMATERIALS MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 330 TABLE 408 REST OF EUROPE: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 331 TABLE 409 REST OF EUROPE: WOUND CLOSURE DEVICE BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 331 TABLE 410 REST OF EUROPE: BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 331 TABLE 411 REST OF EUROPE: BIOMATERIALS MARKET FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 332 TABLE 412 REST OF EUROPE: BIOMATERIALS MARKET FOR URINARY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 332 TABLE 413 REST OF EUROPE: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 332 TABLE 414 REST OF EUROPE: BIOMATERIALS MARKET, BY END USER, 2024–2031 (USD MILLION) 333 TABLE 415 ASIA PACIFIC: BIOMATERIALS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 334 TABLE 416 ASIA PACIFIC: BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 335 TABLE 417 ASIA PACIFIC: METALLIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 335 TABLE 418 ASIA PACIFIC: CERAMIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 335 TABLE 419 ASIA PACIFIC: POLYMERIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 336 TABLE 420 ASIA PACIFIC: NATURAL BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 336 TABLE 421 ASIA PACIFIC: BIOMATERIALS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 337 TABLE 422 ASIA PACIFIC: BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 337 TABLE 423 ASIA PACIFIC: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 338 TABLE 424 ASIA PACIFIC: JOINT REPLACEMENT BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 338 TABLE 425 ASIA PACIFIC: SPINE SURGERY BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 338 TABLE 426 ASIA PACIFIC: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2024–2031 (USD MILLION) 339 TABLE 427 ASIA PACIFIC: BIORESORBABLE TISSUE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 339 TABLE 428 ASIA PACIFIC: FRACTURE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 339 TABLE 429 ASIA PACIFIC: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 340 TABLE 430 ASIA PACIFIC: BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 340 TABLE 431 ASIA PACIFIC: BIOMATERIALS MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 341 TABLE 432 ASIA PACIFIC: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 341 TABLE 433 ASIA PACIFIC: WOUND CLOSURE DEVICE BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 342 TABLE 434 ASIA PACIFIC: BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 342 TABLE 435 ASIA PACIFIC: BIOMATERIALS MARKET FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 342 TABLE 436 ASIA PACIFIC: BIOMATERIALS MARKET FOR URINARY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 343 TABLE 437 ASIA PACIFIC: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 343 TABLE 438 ASIA PACIFIC: BIOMATERIALS MARKET, BY END USER, 2024–2031 (USD MILLION) 343 TABLE 439 CHINA: BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 344 TABLE 440 CHINA: METALLIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 345 TABLE 441 CHINA: CERAMIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 345 TABLE 442 CHINA: POLYMERIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 346 TABLE 443 CHINA: NATURAL BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 346 TABLE 444 CHINA: BIOMATERIALS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 347 TABLE 445 CHINA: BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 347 TABLE 446 CHINA: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 348 TABLE 447 CHINA: JOINT REPLACEMENT BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 348 TABLE 448 CHINA: SPINE SURGERY BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 348 TABLE 449 CHINA: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2024–2031 (USD MILLION) 349 TABLE 450 CHINA: BIORESORBABLE TISSUE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 349 TABLE 451 CHINA: FRACTURE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 349 TABLE 452 CHINA: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 350 TABLE 453 CHINA: BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 350 TABLE 454 CHINA: BIOMATERIALS MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 351 TABLE 455 CHINA: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 351 TABLE 456 CHINA: WOUND CLOSURE DEVICE BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 352 TABLE 457 CHINA: BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 352 TABLE 458 CHINA: BIOMATERIALS MARKET FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 352 TABLE 459 CHINA: BIOMATERIALS MARKET FOR URINARY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 353 TABLE 460 CHINA: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 353 TABLE 461 CHINA: BIOMATERIALS MARKET, BY END USER, 2024–2031 (USD MILLION) 353 TABLE 462 JAPAN: BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 354 TABLE 463 JAPAN: METALLIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 354 TABLE 464 JAPAN: CERAMIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 355 TABLE 465 JAPAN: POLYMERIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 355 TABLE 466 JAPAN: NATURAL BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 356 TABLE 467 JAPAN: BIOMATERIALS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 356 TABLE 468 JAPAN: BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 357 TABLE 469 JAPAN: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 357 TABLE 470 JAPAN: JOINT REPLACEMENT BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 358 TABLE 471 JAPAN: SPINE SURGERY BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 358 TABLE 472 JAPAN: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2024–2031 (USD MILLION) 358 TABLE 473 JAPAN: BIORESORBABLE TISSUE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 359 TABLE 474 JAPAN: FRACTURE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 359 TABLE 475 JAPAN: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 359 TABLE 476 JAPAN: BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 360 TABLE 477 JAPAN: BIOMATERIALS MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 360 TABLE 478 JAPAN: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 361 TABLE 479 JAPAN: WOUND CLOSURE DEVICE BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 361 TABLE 480 JAPAN: BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 361 TABLE 481 JAPAN: BIOMATERIALS MARKET FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 362 TABLE 482 JAPAN: BIOMATERIALS MARKET FOR URINARY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 362 TABLE 483 JAPAN: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 362 TABLE 484 JAPAN: BIOMATERIALS MARKET, BY END USER, 2024–2031 (USD MILLION) 363 TABLE 485 INDIA: BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 363 TABLE 486 INDIA: METALLIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 364 TABLE 487 INDIA: CERAMIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 364 TABLE 488 INDIA: POLYMERIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 365 TABLE 489 INDIA: NATURAL BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 365 TABLE 490 INDIA: BIOMATERIALS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 366 TABLE 491 INDIA: BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 366 TABLE 492 INDIA: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 367 TABLE 493 INDIA: JOINT REPLACEMENT BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 367 TABLE 494 INDIA: SPINE SURGERY BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 367 TABLE 495 INDIA: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2024–2031 (USD MILLION) 368 TABLE 496 INDIA: BIORESORBABLE TISSUE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 368 TABLE 497 INDIA: FRACTURE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 368 TABLE 498 INDIA: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 369 TABLE 499 INDIA: BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 369 TABLE 500 INDIA: BIOMATERIALS MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 370 TABLE 501 INDIA: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 370 TABLE 502 INDIA: WOUND CLOSURE DEVICE BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 371 TABLE 503 INDIA: BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 371 TABLE 504 INDIA: BIOMATERIALS MARKET FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 371 TABLE 505 INDIA: BIOMATERIALS MARKET FOR URINARY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 372 TABLE 506 INDIA: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 372 TABLE 507 INDIA: BIOMATERIALS MARKET, BY END USER, 2024–2031 (USD MILLION) 372 TABLE 508 SOUTH KOREA: BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 373 TABLE 509 SOUTH KOREA: METALLIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 374 TABLE 510 SOUTH KOREA: CERAMIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 374 TABLE 511 SOUTH KOREA: POLYMERIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 375 TABLE 512 SOUTH KOREA: NATURAL BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 375 TABLE 513 SOUTH KOREA: BIOMATERIALS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 376 TABLE 514 SOUTH KOREA: BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 376 TABLE 515 SOUTH KOREA: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 377 TABLE 516 SOUTH KOREA: JOINT REPLACEMENT BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 377 TABLE 517 SOUTH KOREA: SPINE SURGERY BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 377 TABLE 518 SOUTH KOREA: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2024–2031 (USD MILLION) 378 TABLE 519 SOUTH KOREA: BIORESORBABLE TISSUE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 378 TABLE 520 SOUTH KOREA: FRACTURE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 378 TABLE 521 SOUTH KOREA: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 379 TABLE 522 SOUTH KOREA: BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 379 TABLE 523 SOUTH KOREA: BIOMATERIALS MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 380 TABLE 524 SOUTH KOREA: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 380 TABLE 525 SOUTH KOREA: WOUND CLOSURE DEVICE BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 381 TABLE 526 SOUTH KOREA: BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 381 TABLE 527 SOUTH KOREA: BIOMATERIALS MARKET FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 381 TABLE 528 SOUTH KOREA: BIOMATERIALS MARKET FOR URINARY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 382 TABLE 529 SOUTH KOREA: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 382 TABLE 530 SOUTH KOREA: BIOMATERIALS MARKET, BY END USER, 2024–2031 (USD MILLION) 382 TABLE 531 AUSTRALIA: BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 383 TABLE 532 AUSTRALIA: METALLIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 383 TABLE 533 AUSTRALIA: CERAMIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 384 TABLE 534 AUSTRALIA: POLYMERIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 384 TABLE 535 AUSTRALIA: NATURAL BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 385 TABLE 536 AUSTRALIA: BIOMATERIALS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 385 TABLE 537 AUSTRALIA: BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 386 TABLE 538 AUSTRALIA: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 386 TABLE 539 AUSTRALIA: JOINT REPLACEMENT BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 387 TABLE 540 AUSTRALIA: SPINE SURGERY BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 387 TABLE 541 AUSTRALIA: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2024–2031 (USD MILLION) 387 TABLE 542 AUSTRALIA : BIORESORBABLE TISSUE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 388 TABLE 543 AUSTRALIA: FRACTURE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 388 TABLE 544 AUSTRALIA: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 388 TABLE 545 AUSTRALIA: BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 389 TABLE 546 AUSTRALIA: BIOMATERIALS MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 389 TABLE 547 AUSTRALIA: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 390 TABLE 548 AUSTRALIA: WOUND CLOSURE DEVICE BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 390 TABLE 549 AUSTRALIA: BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 390 TABLE 550 AUSTRALIA: BIOMATERIALS MARKET FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 391 TABLE 551 AUSTRALIA: BIOMATERIALS MARKET FOR URINARY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 391 TABLE 552 AUSTRALIA: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 391 TABLE 553 AUSTRALIA: BIOMATERIALS MARKET, BY END USER, 2024–2031 (USD MILLION) 392 TABLE 554 REST OF ASIA PACIFIC: BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 392 TABLE 555 REST OF ASIA PACIFIC: METALLIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 393 TABLE 556 REST OF ASIA PACIFIC: CERAMIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 393 TABLE 557 REST OF ASIA PACIFIC: POLYMERIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 394 TABLE 558 REST OF ASIA PACIFIC: NATURAL BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 394 TABLE 559 REST OF ASIA PACIFIC: BIOMATERIALS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 395 TABLE 560 REST OF ASIA PACIFIC: BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 395 TABLE 561 REST OF ASIA PACIFIC: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 396 TABLE 562 REST OF ASIA PACIFIC: JOINT REPLACEMENT BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 396 TABLE 563 REST OF ASIA PACIFIC: SPINE SURGERY BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 396 TABLE 564 REST OF ASIA PACIFIC: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2024–2031 (USD MILLION) 397 TABLE 565 REST OF ASIA PACIFIC : BIORESORBABLE TISSUE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 397 TABLE 566 REST OF ASIA PACIFIC: FRACTURE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 397 TABLE 567 REST OF ASIA PACIFIC: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 398 TABLE 568 REST OF ASIA PACIFIC: BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 398 TABLE 569 REST OF ASIA PACIFIC: BIOMATERIALS MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 399 TABLE 570 REST OF ASIA PACIFIC: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 399 TABLE 571 REST OF ASIA PACIFIC: WOUND CLOSURE DEVICE BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 400 TABLE 572 REST OF ASIA PACIFIC: BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 400 TABLE 573 REST OF ASIA PACIFIC: BIOMATERIALS MARKET FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 400 TABLE 574 REST OF ASIA PACIFIC: BIOMATERIALS MARKET FOR URINARY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 401 TABLE 575 REST OF ASIA PACIFIC: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 401 TABLE 576 REST OF ASIA PACIFIC: BIOMATERIALS MARKET, BY END USER, 2024–2031 (USD MILLION) 401 TABLE 577 LATIN AMERICA: BIOMATERIALS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 402 TABLE 578 LATIN AMERICA: BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 402 TABLE 579 LATIN AMERICA: METALLIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 403 TABLE 580 LATIN AMERICA: CERAMIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 403 TABLE 581 LATIN AMERICA: POLYMERIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 404 TABLE 582 LATIN AMERICA: NATURAL BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 404 TABLE 583 LATIN AMERICA: BIOMATERIALS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 405 TABLE 584 LATIN AMERICA: BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 405 TABLE 585 LATIN AMERICA: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 406 TABLE 586 LATIN AMERICA: JOINT REPLACEMENT BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 406 TABLE 587 LATIN AMERICA: SPINE SURGERY BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 406 TABLE 588 LATIN AMERICA: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2024–2031 (USD MILLION) 407 TABLE 589 LATIN AMERICA: BIORESORBABLE TISSUE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 407 TABLE 590 LATIN AMERICA: FRACTURE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 407 TABLE 591 LATIN AMERICA: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 408 TABLE 592 LATIN AMERICA: BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 408 TABLE 593 LATIN AMERICA: BIOMATERIALS MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 409 TABLE 594 LATIN AMERICA: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 409 TABLE 595 LATIN AMERICA: WOUND CLOSURE DEVICE BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 410 TABLE 596 LATIN AMERICA: BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 410 TABLE 597 LATIN AMERICA: BIOMATERIALS MARKET FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 410 TABLE 598 LATIN AMERICA: BIOMATERIALS MARKET FOR URINARY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 411 TABLE 599 LATIN AMERICA: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 411 TABLE 600 LATIN AMERICA: BIOMATERIALS MARKET, BY END USER, 2024–2031 (USD MILLION) 411 TABLE 601 BRAZIL: BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 412 TABLE 602 BRAZIL: METALLIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 412 TABLE 603 BRAZIL: CERAMIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 413 TABLE 604 BRAZIL: POLYMERIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 413 TABLE 605 BRAZIL: NATURAL BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 414 TABLE 606 BRAZIL: BIOMATERIALS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 414 TABLE 607 BRAZIL: BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 415 TABLE 608 BRAZIL: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 415 TABLE 609 BRAZIL: JOINT REPLACEMENT BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 416 TABLE 610 BRAZIL: SPINE SURGERY BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 416 TABLE 611 BRAZIL: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2024–2031 (USD MILLION) 416 TABLE 612 BRAZIL: BIORESORBABLE TISSUE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 417 TABLE 613 BRAZIL: FRACTURE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 417 TABLE 614 BRAZIL: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 417 TABLE 615 BRAZIL: BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 418 TABLE 616 BRAZIL: BIOMATERIALS MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 418 TABLE 617 BRAZIL: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 419 TABLE 618 BRAZIL: WOUND CLOSURE DEVICE BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 419 TABLE 619 BRAZIL: BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 419 TABLE 620 BRAZIL: BIOMATERIALS MARKET FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 420 TABLE 621 BRAZIL: BIOMATERIALS MARKET FOR URINARY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 420 TABLE 622 BRAZIL: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 420 TABLE 623 BRAZIL: BIOMATERIALS MARKET, BY END USER, 2024–2031 (USD MILLION) 421 TABLE 624 MEXICO: BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 421 TABLE 625 MEXICO: METALLIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 422 TABLE 626 MEXICO: CERAMIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 422 TABLE 627 MEXICO: POLYMERIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 423 TABLE 628 MEXICO: NATURAL BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 423 TABLE 629 MEXICO: BIOMATERIALS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 424 TABLE 630 MEXICO: BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 424 TABLE 631 MEXICO: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 425 TABLE 632 MEXICO: JOINT REPLACEMENT BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 425 TABLE 633 MEXICO: SPINE SURGERY BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 425 TABLE 634 MEXICO: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2024–2031 (USD MILLION) 426 TABLE 635 MEXICO: BIORESORBABLE TISSUE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 426 TABLE 636 MEXICO: FRACTURE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 426 TABLE 637 MEXICO: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 427 TABLE 638 MEXICO: BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 427 TABLE 639 MEXICO: BIOMATERIALS MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 428 TABLE 640 MEXICO: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 428 TABLE 641 MEXICO: WOUND CLOSURE DEVICE BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 429 TABLE 642 MEXICO: BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 429 TABLE 643 MEXICO: BIOMATERIALS MARKET FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 429 TABLE 644 MEXICO: BIOMATERIALS MARKET FOR URINARY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 430 TABLE 645 MEXICO: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 430 TABLE 646 MEXICO: BIOMATERIALS MARKET, BY END USER, 2024–2031 (USD MILLION) 430 TABLE 647 ARGENTINA: BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 431 TABLE 648 ARGENTINA: METALLIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 431 TABLE 649 ARGENTINA: CERAMIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 432 TABLE 650 ARGENTINA: POLYMERIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 432 TABLE 651 ARGENTINA: NATURAL BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 433 TABLE 652 ARGENTINA: BIOMATERIALS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 433 TABLE 653 ARGENTINA: BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 434 TABLE 654 ARGENTINA: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 434 TABLE 655 ARGENTINA: JOINT REPLACEMENT BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 435 TABLE 656 ARGENTINA: SPINE SURGERY BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 435 TABLE 657 ARGENTINA: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2024–2031 (USD MILLION) 435 TABLE 658 ARGENTINA : BIORESORBABLE TISSUE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 436 TABLE 659 ARGENTINA: FRACTURE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 436 TABLE 660 ARGENTINA: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 436 TABLE 661 ARGENTINA: BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 437 TABLE 662 ARGENTINA: BIOMATERIALS MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 437 TABLE 663 ARGENTINA: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 438 TABLE 664 ARGENTINA: WOUND CLOSURE DEVICE BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 438 TABLE 665 ARGENTINA: BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 438 TABLE 666 ARGENTINA: BIOMATERIALS MARKET FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 439 TABLE 667 ARGENTINA: BIOMATERIALS MARKET FOR URINARY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 439 TABLE 668 ARGENTINA: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 439 TABLE 669 ARGENTINA: BIOMATERIALS MARKET, BY END USER, 2024–2031 (USD MILLION) 440 TABLE 670 REST OF LATIN AMERICA: BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 440 TABLE 671 REST OF LATIN AMERICA: METALLIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 441 TABLE 672 REST OF LATIN AMERICA: CERAMIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 441 TABLE 673 REST OF LATIN AMERICA: POLYMERIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 442 TABLE 674 REST OF LATIN AMERICA: NATURAL BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 442 TABLE 675 REST OF LATIN AMERICA: BIOMATERIALS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 443 TABLE 676 REST OF LATIN AMERICA: BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 443 TABLE 677 REST OF LATIN AMERICA: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 444 TABLE 678 REST OF LATIN AMERICA: JOINT REPLACEMENT BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 444 TABLE 679 REST OF LATIN AMERICA: SPINE SURGERY BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 444 TABLE 680 REST OF LATIN AMERICA: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2024–2031 (USD MILLION) 445 TABLE 681 REST OF LATIN AMERICA : BIORESORBABLE TISSUE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 445 TABLE 682 REST OF LATIN AMERICA: FRACTURE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 445 TABLE 683 REST OF LATIN AMERICA: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 446 TABLE 684 REST OF LATIN AMERICA: BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 446 TABLE 685 REST OF LATIN AMERICA: BIOMATERIALS MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 447 TABLE 686 REST OF LATIN AMERICA: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 447 TABLE 687 REST OF LATIN AMERICA: WOUND CLOSURE DEVICE BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 448 TABLE 688 REST OF LATIN AMERICA: BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 448 TABLE 689 REST OF LATIN AMERICA: BIOMATERIALS MARKET FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 448 TABLE 690 REST OF LATIN AMERICA: BIOMATERIALS MARKET FOR URINARY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 449 TABLE 691 REST OF LATIN AMERICA: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 449 TABLE 692 REST OF LATIN AMERICA: BIOMATERIALS MARKET, BY END USER, 2024–2031 (USD MILLION) 449 TABLE 693 MIDDLE EAST: BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION) 450 TABLE 694 MIDDLE EAST: BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 450 TABLE 695 MIDDLE EAST: METALLIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 451 TABLE 696 MIDDLE EAST: CERAMIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 451 TABLE 697 MIDDLE EAST: POLYMERIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 452 TABLE 698 MIDDLE EAST: NATURAL BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 452 TABLE 699 MIDDLE EAST: BIOMATERIALS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 453 TABLE 700 MIDDLE EAST: BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 453 TABLE 701 MIDDLE EAST: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 454 TABLE 702 MIDDLE EAST: JOINT REPLACEMENT BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 454 TABLE 703 MIDDLE EAST: SPINE SURGERY BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 454 TABLE 704 MIDDLE EAST: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2024–2031 (USD MILLION) 455 TABLE 705 MIDDLE EAST: BIORESORBABLE TISSUE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 455 TABLE 706 MIDDLE EAST: FRACTURE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 455 TABLE 707 MIDDLE EAST: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 456 TABLE 708 MIDDLE EAST: BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 456 TABLE 709 MIDDLE EAST: BIOMATERIALS MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 457 TABLE 710 MIDDLE EAST: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 457 TABLE 711 MIDDLE EAST: WOUND CLOSURE DEVICE BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 458 TABLE 712 MIDDLE EAST: BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 458 TABLE 713 MIDDLE EAST: BIOMATERIALS MARKET FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 458 TABLE 714 MIDDLE EAST: BIOMATERIALS MARKET FOR URINARY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 459 TABLE 715 MIDDLE EAST: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 459 TABLE 716 MIDDLE EAST: BIOMATERIALS MARKET, BY END USER, 2024–2031 (USD MILLION) 459 TABLE 717 GCC COUNTRIES: BIOMATERIALS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 460 TABLE 718 GCC COUNTRIES: BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 460 TABLE 719 GCC COUNTRIES: METALLIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 461 TABLE 720 GCC COUNTRIES: CERAMIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 461 TABLE 721 GCC COUNTRIES: POLYMERIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 462 TABLE 722 GCC COUNTRIES: NATURAL BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 462 TABLE 723 GCC COUNTRIES: BIOMATERIALS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 463 TABLE 724 GCC COUNTRIES: BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 463 TABLE 725 GCC COUNTRIES: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 464 TABLE 726 GCC COUNTRIES: JOINT REPLACEMENT BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 464 TABLE 727 GCC COUNTRIES: SPINE SURGERY BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 464 TABLE 728 GCC COUNTRIES: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2024–2031 (USD MILLION) 465 TABLE 729 GCC COUNTRIES: BIORESORBABLE TISSUE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 465 TABLE 730 GCC COUNTRIES: FRACTURE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 465 TABLE 731 GCC COUNTRIES: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 466 TABLE 732 GCC COUNTRIES: BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 466 TABLE 733 GCC COUNTRIES: BIOMATERIALS MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 467 TABLE 734 GCC COUNTRIES: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 467 TABLE 735 GCC COUNTRIES: WOUND CLOSURE DEVICE BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 468 TABLE 736 GCC COUNTRIES: BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 468 TABLE 737 GCC COUNTRIES: BIOMATERIALS MARKET FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 468 TABLE 738 GCC COUNTRIES: BIOMATERIALS MARKET FOR URINARY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 469 TABLE 739 GCC COUNTRIES: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 469 TABLE 740 GCC COUNTRIES: BIOMATERIALS MARKET, BY END USER, 2024–2031 (USD MILLION) 469 TABLE 741 KINGDOM OF SAUDI ARABIA: BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 470 TABLE 742 KINGDOM OF SAUDI ARABIA: METALLIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 470 TABLE 743 KINGDOM OF SAUDI ARABIA: CERAMIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 471 TABLE 744 KINGDOM OF SAUDI ARABIA: POLYMERIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 471 TABLE 745 KINGDOM OF SAUDI ARABIA: NATURAL BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 472 TABLE 746 KINGDOM OF SAUDI ARABIA: BIOMATERIALS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 472 TABLE 747 KINGDOM OF SAUDI ARABIA: BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 473 TABLE 748 KINGDOM OF SAUDI ARABIA: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 473 TABLE 749 KINGDOM OF SAUDI ARABIA: JOINT REPLACEMENT BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 474 TABLE 750 KINGDOM OF SAUDI ARABIA: SPINE SURGERY BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 474 TABLE 751 KINGDOM OF SAUDI ARABIA: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2024–2031 (USD MILLION) 474 TABLE 752 KINGDOM OF SAUDI ARABIA: BIORESORBABLE TISSUE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 475 TABLE 753 KINGDOM OF SAUDI ARABIA: FRACTURE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 475 TABLE 754 KINGDOM OF SAUDI ARABIA: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 475 TABLE 755 KINGDOM OF SAUDI ARABIA: BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 476 TABLE 756 KINGDOM OF SAUDI ARABIA: BIOMATERIALS MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 476 TABLE 757 KINGDOM OF SAUDI ARABIA: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 477 TABLE 758 KINGDOM OF SAUDI ARABIA: WOUND CLOSURE DEVICE BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 477 TABLE 759 KINGDOM OF SAUDI ARABIA: BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 477 TABLE 760 KINGDOM OF SAUDI ARABIA: BIOMATERIALS MARKET FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 478 TABLE 761 KINGDOM OF SAUDI ARABIA: BIOMATERIALS MARKET FOR URINARY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 478 TABLE 762 KINGDOM OF SAUDI ARABIA: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 478 TABLE 763 KINGDOM OF SAUDI ARABIA: BIOMATERIALS MARKET, BY END USER, 2024–2031 (USD MILLION) 479 TABLE 764 UAE: BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 479 TABLE 765 UAE: METALLIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 480 TABLE 766 UAE: CERAMIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 480 TABLE 767 UAE: POLYMERIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 481 TABLE 768 UAE: NATURAL BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 481 TABLE 769 UAE: BIOMATERIALS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 482 TABLE 770 UAE: BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 482 TABLE 771 UAE: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 483 TABLE 772 UAE: JOINT REPLACEMENT BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 483 TABLE 773 UAE: SPINE SURGERY BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 483 TABLE 774 UAE: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2024–2031 (USD MILLION) 484 TABLE 775 UAE: BIORESORBABLE TISSUE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 484 TABLE 776 UAE: FRACTURE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 484 TABLE 777 UAE: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 485 TABLE 778 UAE: BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 485 TABLE 779 UAE: BIOMATERIALS MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 486 TABLE 780 UAE: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 486 TABLE 781 UAE: WOUND CLOSURE DEVICE BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 487 TABLE 782 UAE: BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 487 TABLE 783 UAE: BIOMATERIALS MARKET FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 487 TABLE 784 UAE: BIOMATERIALS MARKET FOR URINARY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 488 TABLE 785 UAE: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 488 TABLE 786 UAE: BIOMATERIALS MARKET, BY END USER, 2024–2031 (USD MILLION) 488 TABLE 787 REST OF GCC COUNTRIES: BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 489 TABLE 788 REST OF GCC COUNTRIES: METALLIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 489 TABLE 789 REST OF GCC COUNTRIES: CERAMIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 490 TABLE 790 REST OF GCC COUNTRIES: POLYMERIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 490 TABLE 791 REST OF GCC COUNTRIES: NATURAL BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 491 TABLE 792 REST OF GCC COUNTRIES: BIOMATERIALS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 491 TABLE 793 REST OF GCC COUNTRIES: BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 492 TABLE 794 REST OF GCC COUNTRIES: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 492 TABLE 795 REST OF GCC COUNTRIES: JOINT REPLACEMENT BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 493 TABLE 796 REST OF GCC COUNTRIES: SPINE SURGERY BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 493 TABLE 797 REST OF GCC COUNTRIES: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2024–2031 (USD MILLION) 493 TABLE 798 REST OF GCC COUNTRIES: BIORESORBABLE TISSUE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 494 TABLE 799 REST OF GCC COUNTRIES: FRACTURE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 494 TABLE 800 REST OF GCC COUNTRIES: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 494 TABLE 801 REST OF GCC COUNTRIES: BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 495 TABLE 802 REST OF GCC COUNTRIES: BIOMATERIALS MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 495 TABLE 803 REST OF GCC COUNTRIES: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 496 TABLE 804 REST OF GCC COUNTRIES: WOUND CLOSURE DEVICE BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 496 TABLE 805 REST OF GCC COUNTRIES: BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 496 TABLE 806 REST OF GCC COUNTRIES: BIOMATERIALS MARKET FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 497 TABLE 807 REST OF GCC COUNTRIES: BIOMATERIALS MARKET FOR URINARY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 497 TABLE 808 REST OF GCC COUNTRIES: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 497 TABLE 809 REST OF GCC COUNTRIES: BIOMATERIALS MARKET, BY END USER, 2024–2031 (USD MILLION) 498 TABLE 810 REST OF MIDDLE EAST: BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 498 TABLE 811 REST OF MIDDLE EAST: METALLIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 499 TABLE 812 REST OF MIDDLE EAST: CERAMIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 499 TABLE 813 REST OF MIDDLE EAST: POLYMERIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 500 TABLE 814 REST OF MIDDLE EAST: NATURAL BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 500 TABLE 815 REST OF MIDDLE EAST: BIOMATERIALS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 501 TABLE 816 REST OF MIDDLE EAST: BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 501 TABLE 817 REST OF MIDDLE EAST: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 502 TABLE 818 REST OF MIDDLE EAST: JOINT REPLACEMENT BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 502 TABLE 819 REST OF MIDDLE EAST: SPINE SURGERY BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 502 TABLE 820 REST OF MIDDLE EAST: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2024–2031 (USD MILLION) 503 TABLE 821 REST OF MIDDLE EAST: BIORESORBABLE TISSUE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 503 TABLE 822 REST OF MIDDLE EAST: FRACTURE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 503 TABLE 823 REST OF MIDDLE EAST: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 504 TABLE 824 REST OF MIDDLE EAST: BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 504 TABLE 825 REST OF MIDDLE EAST: BIOMATERIALS MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 505 TABLE 826 REST OF MIDDLE EAST: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 505 TABLE 827 REST OF MIDDLE EAST: WOUND CLOSURE DEVICE BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 506 TABLE 828 REST OF MIDDLE EAST: BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 506 TABLE 829 REST OF MIDDLE EAST: BIOMATERIALS MARKET FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 506 TABLE 830 REST OF MIDDLE EAST: BIOMATERIALS MARKET FOR URINARY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 507 TABLE 831 REST OF MIDDLE EAST: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 507 TABLE 832 REST OF MIDDLE EAST: BIOMATERIALS MARKET, BY END USER, 2024–2031 (USD MILLION) 507 TABLE 833 AFRICA: BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 508 TABLE 834 AFRICA: METALLIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 509 TABLE 835 AFRICA: CERAMIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 509 TABLE 836 AFRICA: POLYMERIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 510 TABLE 837 AFRICA: NATURAL BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 510 TABLE 838 AFRICA: BIOMATERIALS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 511 TABLE 839 AFRICA: BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 511 TABLE 840 AFRICA: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 512 TABLE 841 AFRICA: JOINT REPLACEMENT BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 512 TABLE 842 AFRICA: SPINE SURGERY BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 512 TABLE 843 AFRICA: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2024–2031 (USD MILLION) 513 TABLE 844 AFRICA : BIORESORBABLE TISSUE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 513 TABLE 845 AFRICA: FRACTURE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 513 TABLE 846 AFRICA: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 514 TABLE 847 AFRICA: BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 514 TABLE 848 AFRICA: BIOMATERIALS MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 515 TABLE 849 AFRICA: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 515 TABLE 850 AFRICA: WOUND CLOSURE DEVICE BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 516 TABLE 851 AFRICA: BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 516 TABLE 852 AFRICA: BIOMATERIALS MARKET FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 516 TABLE 853 AFRICA: BIOMATERIALS MARKET FOR URINARY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 517 TABLE 854 AFRICA: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 517 TABLE 855 AFRICA: BIOMATERIALS MARKET, BY END USER, 2024–2031 (USD MILLION) 517 TABLE 856 STRATEGIES ADOPTED BY KEY PLAYERS IN BIOMATERIALS MARKET, JANAURY 2023−FEBRUARY 2026 518 TABLE 857 BIOMATERIALS MARKET: DEGREE OF COMPETITION 521 TABLE 858 BIOMATERIALS MARKET: REGION FOOTPRINT 525 TABLE 859 BIOMATERIALS MARKET: TYPE FOOTPRINT 526 TABLE 860 BIOMATERIALS MARKET: APPLICATION FOOTPRINT 527 TABLE 861 LIST OF KEY STARTUPS/SME PLAYERS IN BIOMATERIALS MARKET 530 TABLE 862 BIOMATERIALS: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SME PLAYERS, BY TYPE AND REGION 531 TABLE 863 BIOMATERIALS MARKET: PRODUCT LAUNCHES, JANUARY 2023–FEBRUARY 2026 534 TABLE 864 BIOMATERIALS MARKET: DEALS, JANUARY 2022–FEBRUARY 2026 534 TABLE 865 BIOMATERIALS MARKET: EXPANSIONS, JANUARY 2023–FEBRUARY 2026 535 TABLE 866 BASF SE: COMPANY OVERVIEW 536 TABLE 867 BASF SE: PRODUCTS/SERVICES/SOLUTIONS OFFERED 537 TABLE 868 BASF SE: DEALS, JANUARY 2023–FEBRUARY 2026 538 TABLE 869 BASF SE: OTHER DEVELOPMENTS, JANUARY 2023–FEBRUARY 2026 539 TABLE 870 COVESTRO AG: COMPANY OVERVIEW 540 TABLE 871 COVESTRO AG: PRODUCTS/SERVICES/SOLUTIONS OFFERED 541 TABLE 872 COVESTRO AG: PRODUCT LAUNCHES, JANUARY 2023–FEBRUARY 2026 543 TABLE 873 COVESTRO AG: DEALS, JANUARY 2023–FEBRUARY 2026 543 TABLE 874 COVESTRO AG: EXPANSIONS, JANUARY 2023–FEBRUARY 2026 543 TABLE 875 COVESTRO AG: OTHER DEVELOPMENTS, JANUARY 2023–FEBRUARY 2026 544 TABLE 876 CELANESE CORPORATION: COMPANY OVERVIEW 545 TABLE 877 CELANESE CORPORATION: PRODUCTS/SERVICES/SOLUTIONS OFFERED 546 TABLE 878 CELANESE CORPORATION: DEALS, JANUARY 2023–FEBRUARY 2026 548 TABLE 879 CARPENTER TECHNOLOGY CORPORATION: COMPANY OVERVIEW 550 TABLE 880 CARPENTER TECHNOLOGY CORPORATION: PRODUCTS/SERVICES/SOLUTIONS OFFERED 551 TABLE 881 CARPPENTER TECHNOLOGY CORPORATION: OTHER DEVELOPMENTS, JANUARY 2023–FEBRUARY 2026 552 TABLE 882 EVONIK INDUSTRIES AG: COMPANY OVERVIEW 554 TABLE 883 EVONIK INDUSTRIES AG: PRODUCTS/SERVICES/SOLUTIONS OFFERED 555 TABLE 884 EVONIK INDUSTRIES AG: PRODUCT LAUNCHES, JANUARY 2023–FEBRUARY 2026 558 TABLE 885 EVONIK INDUSTRIES AG: DEALS, JANUARY 2023–FEBRUARY 2026 558 TABLE 886 DSM: COMPANY OVERVIEW 560 TABLE 887 DSM: PRODUCTS/SERVICES/SOLUTIONS OFFERED 561 TABLE 888 DSM: DEALS, JANUARY 2023–FEBRUARY 2026 563 TABLE 889 DSM: EXPANSIONS, JANUARY 2023–FEBRUARY 2026 564 TABLE 890 CORBION NV: COMPANY OVERVIEW 565 TABLE 891 CORBION NV: PRODUCTS/SERVICES/SOLUTIONS OFFERED 566 TABLE 892 CORBION NV: EXPANSIONS, JANUARY 2023–FEBRUARY 2026 568 TABLE 893 VICTREX PLC: COMPANY OVERVIEW 569 TABLE 894 VICTREX PLC: PRODUCTS/SERVICES/SOLUTIONS OFFERED 570 TABLE 895 VICTREX PLC: PRODUCT LAUNCHES, JANUARY 2023–FEBRUARY 2026 571 TABLE 896 VICTREX PLC: EXPANSIONS, JANUARY 2023–FEBRUARY 2026 571 TABLE 897 MITSUBISHI CHEMICAL CORPORATION: COMPANY OVERVIEW 572 TABLE 898 MITSUBISHI CHEMICAL CORPORATION: PRODUCTS/SERVICES/SOLUTIONS OFFERED 573 TABLE 899 COORSTEK INC.: COMPANY OVERVIEW 574 TABLE 900 COORSTEK INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 574 TABLE 901 BERKELEY ADVANCED BIOMATERIALS: COMPANY OVERVIEW 575 TABLE 902 BERKELEY ADVANCED BIOMATERIALS: PRODUCTS/SERVICES/SOLUTIONS OFFERED 575 TABLE 903 CAM BIOCERAMICS B.V.: COMPANY OVERVIEW 577 TABLE 904 CAM BIOCERAMICS B.V.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 577 TABLE 905 CAM BIOCERAMICS B.V.: DEALS, JANUARY 2023–FEBRUARY 2026 578 TABLE 906 ZEUS COMPANY INC.: COMPANY OVERVIEW 579 TABLE 907 ZEUS COMPANY INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 579 TABLE 908 ZEUS COMPANY INC.: PRODUCT LAUNCHES, JANUARY 2023–FEBRUARY 2026 581 TABLE 909 ZEUS COMPANY INC.: EXPANSIONS, JANUARY 2023–FEBRUARY 2026 581 TABLE 910 AMETEK.INC.: COMPANY OVERVIEW 582 TABLE 911 AMETEK INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 583 TABLE 912 AMETEK INC.: DEALS, JANUARY 2023–FEBRUARY 2026 583 TABLE 913 AMETEK.INC.: EXPANSIONS, JANUARY 2023–FEBRUARY 2026 584 TABLE 914 GELITA AG: COMPANY OVERVIEW 585 TABLE 915 GELITA AG: PRODUCTS/SERVICES/SOLUTIONS OFFERED 585 TABLE 916 GELITA AG.: PRODUCT LAUNCHES, JANUARY 2023–FEBRUARY 2026 587 TABLE 917 COLLAGEN SOLUTIONS (US) LLC: COMPANY OVERVIEW 588 TABLE 918 BIOCOMPOSITES: COMPANY OVERVIEW 589 TABLE 919 NOBLE BIOMATERIALS, INC.: COMPANY OVERVIEW 590 TABLE 920 REGENITY: COMPANY OVERVIEW 590 TABLE 921 KURARAY CO., LTD.: COMPANY OVERVIEW 591 TABLE 922 SOLESIS: COMPANY OVERVIEW 593 TABLE 923 INSTITUT STRAUMANN AG: COMPANY OVERVIEW 594 TABLE 924 FOSTER CORPORATION: COMPANY OVERVIEW 595 TABLE 925 CDI PRODUCTS: COMPANY OVERVIEW 596 TABLE 926 REVBIO, INC.: COMPANY OVERVIEW 597 TABLE 927 IMPACT ANALYSIS OF SUPPLY- AND DEMAND-SIDE FACTORS IN BIOMATERIALS MARKET 606 TABLE 928 BIOMATERIALS MARKET: RISK ANALYSIS 609 FIGURE 1 BIOMATERIALS MARKET SEGMENTATION 59 FIGURE 2 BIOMATERIALS MARKET: REGIONAL SCOPE 60 FIGURE 3 BIOMATERIALS MARKET: YEARS CONSIDERED 60 FIGURE 4 BIOMATERIALS MARKET SCENARIO 63 FIGURE 5 GLOBAL BIOMATERIALS MARKET SIZE, 2024–2031 (USD MILLION) 64 FIGURE 6 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN BIOMATERIALS MARKET, 2023–2026 64 FIGURE 7 DISRUPTIONS INFLUENCING BIOMATERIALS MARKET GROWTH 65 FIGURE 8 HIGH-GROWTH SEGMENTS IN BIOMATERIALS MARKET, BY TYPE, APPLICATION, END USER, AND REGION (2026–2031) 66 FIGURE 9 ASIA PACIFIC TO REGISTER HIGHEST CAGR IN BIOMATERIALS MARKET, IN TERMS OF VALUE, DURING FORECAST PERIOD 67 FIGURE 10 RISING ADVANCEMENTS IN SMART, BIOCOMPATIBLE, AND 3D PRINTED BIOMATERIALS TO DRIVE MARKET 68 FIGURE 11 US AND METALLIC BIOMATERIALS ACCOUNTED FOR LARGEST MARKET SHARE IN 2025 69 FIGURE 12 CHINA TO REGISTER HIGHEST GROWTH RATE DURING STUDY PERIOD 70 FIGURE 13 BIOMATERIALS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 71 FIGURE 14 BIOMATERIALS MARKET: PORTER’S FIVE FORCES ANALYSIS 79 FIGURE 15 BIOMATERIALS MARKET: VALUE CHAIN ANALYSIS 83 FIGURE 16 BIOMATERIALS MARKET ECOSYSTEM ANALYSIS 84 FIGURE 17 INDICATIVE SELLING PRICE OF BIOMATERIALS, BY KEY PLAYER, 2025 (USD) 87 FIGURE 18 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS IN BIOMATERIALS MARKET 105 FIGURE 19 FUNDING AND NUMBER OF DEALS IN BIOMATERIALS MARKET, 2025 (USD MILLION) 105 FIGURE 20 TOP APPLICANTS/OWNERS (COMPANIES) FOR BIOMATERIAL PATENTS, 2015–2025 115 FIGURE 21 IMPACT OF AI/GEN AI ON BIOMATERIALS MARKET 117 FIGURE 22 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS, BY TYPE 127 FIGURE 23 KEY BUYING CRITERIA, BY END USER 128 FIGURE 24 NORTH AMERICA: BIOMATERIALS MARKET SNAPSHOT 237 FIGURE 25 ASIA PACIFIC: BIOMATERIALS MARKET SNAPSHOT 334 FIGURE 26 REVENUE ANALYSIS OF KEY PLAYERS IN BIOMATERIALS MARKET, 2023–2025 (USD MILLION) 520 FIGURE 27 BIOMATERIALS MARKET SHARE ANALYSIS OF KEY PLAYERS (2025) 521 FIGURE 28 BIOMATERIALS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025 523 FIGURE 29 BIOMATERIALS MARKET: COMPANY FOOTPRINT 524 FIGURE 30 BIOMATERIALS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025 529 FIGURE 31 EV/EBITDA OF KEY VENDORS 531 FIGURE 32 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS 532 FIGURE 33 BRAND/PRODUCT COMPARATIVE ANALYSIS, BY TYPE, IN BIOMATERIALS MARKET 533 FIGURE 34 BASF SE: COMPANY SNAPSHOT 537 FIGURE 35 COVESTRO AG: COMPANY SNAPSHOT 541 FIGURE 36 CELANESE CORPORATION: COMPANY SNAPSHOT 545 FIGURE 37 CARPENTER TECHNOLOGY CORPORATION: COMPANY SNAPSHOT 551 FIGURE 38 EVONIK INDUSTRIES AG: COMPANY SNAPSHOT 555 FIGURE 39 DSM: COMPANY SNAPSHOT 561 FIGURE 40 CORBION NV: COMPANY SNAPSHOT 566 FIGURE 41 VICTREX PLC: COMPANY SNAPSHOT 570 FIGURE 42 MITSUBISHI CHEMICAL CORPORATION: COMPANY SNAPSHOT 572 FIGURE 43 AMETEK.INC.: COMPANY SNAPSHOT 582 FIGURE 44 BIOMATERIALS MARKET: RESEARCH DESIGN 598 FIGURE 45 BIOMATERIALS MARKET: BREAKDOWN OF DEMAND- AND SUPPLY-SIDE PRIMARIES 600 FIGURE 46 BIOMATERIALS MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2025 601 FIGURE 47 BIOMATERIALS MARKET SIZE ESTIMATION: COMPANY REVENUE ANALYSIS-BASED ESTIMATION, 2025 602 FIGURE 48 REVENUE SHARE ANALYSIS: ILLUSTRATIVE EXAMPLE OF COVESTRO AG (2025) 602 FIGURE 49 BIOMATERIALS MARKET SIZE VALIDATION FROM PRIMARY SOURCES 603 FIGURE 50 BIOMATERIALS MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 604 FIGURE 51 BIOMATERIALS MARKET: CAGR PROJECTIONS 605 FIGURE 52 DATA TRIANGULATION METHODOLOGY IN BIOMATERIALS MARKET 607

同分類最新報告（醫療與生命科學）

查看醫療與生命科學全部報告 →

量子訊息有限公司為 MarketsandMarkets 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們